基础利率手册——销售增长:整合过去以更好预见未来

2015 · report · 原文约 8936 词
译文与英文原文逐段对齐可在本页展开英文,也可打开发布者原址核对上下文。
打开来源正文

全球金融策略 www.credit-suisse.com

GLOBAL FINANCIAL STRATEGIES www.credit-suisse.com

基础比率手册——销售增长:整合过往,更好地预判未来

The Base Rate Book – Sales Growth Integrating the Past to Better Anticipate the Future

May 4, 2015
   50
Authors
   45
Michael J. Mauboussin   40   Base Rates
May 4, 2015
   50
Authors
   45
Michael J. Mauboussin   40   Base Rates

频率(百分比)

Frequency (Percent)

35 当前预测 30 丹·卡拉汉,CFA 25 [email protected]

35 Current Estimates 30 Dan Callahan, CFA 25 [email protected]

原件此处是表格,PDF 抽取时列结构已丢失,下面只剩按列读出的数字,行列对应关系无法还原。核对数据请打开来源正文。

20
15
10
5
0
   <(25)   (5)-0   5-10
   0-5   >45
   (25)-(20)   (20)-(15)   (15)-(10)   (10)-(5)   10-15   15-20   20-25   25-30   30-35   35-40   40-45
20
15
10
5
0
   <(25)   (5)-0   5-10
   0-5   >45
   (25)-(20)   (20)-(15)   (15)-(10)   (10)-(5)   10-15   15-20   20-25   25-30   30-35   35-40   40-45

3 年销售复合年增长率(百分比)

3-Year Sales CAGR (Percent)

“当‘苍白的’统计信息与人们对某个案例的个人印象不符时,它往往被随手丢弃。”

“‘Pallid’ statistical information is routinely discarded when it is incompatible with one’s personal impressions of a case.”

丹尼尔·卡尼曼1

Daniel Kahneman1

成功的主动投资,要求你的预测与市场当下所贴现的不同。

Successful active investing requires a forecast that is different than what the market is discounting.

对与我们切身相关的结果所做的预测,普遍受到乐观偏差与过度自信偏差的干扰。

Forecasts about outcomes relevant to us commonly suffer from biases of optimism and overconfidence.

研究表明,考察一个恰当参照类别的历史结果,能够提升预测的质量。

Research reveals that consideration of the results for an appropriate reference class can enhance the quality of forecasts.

对多数公司而言,销售增长是最重要的价值驱动因素。

Sales growth is the most important value driver for most companies.

本报告展示了一个大样本公司群体在二十多年里的销售增长率基础比率。我们把这些公司按十分位分组,便于快速找到合适的参照类别。

This report shows the base rate of sales growth rates for a large sample of companies over more than two decades. We sort the companies into deciles, allowing for easy identification of an appropriate reference class.

我们还提供了一套方法,把自己的观点与基础比率结合起来,以提升预测的质量。

We provide a method to integrate our views with the base rates to sharpen the quality of forecasts.

我们分享了若干正面与负面的案例研究,用以呈现一些极端值的实际表现。

We share some case studies, positive and negative, to demonstrate results for some outliers.

引言

Introduction

2015 年 2 月的一次财报电话会上,特斯拉汽车董事长兼首席执行官埃隆·马斯克,为公司勾画了一条十年内市值达到约 7000 亿美元的路径。2 这个数字接近苹果公司当时的规模,而苹果是当时全球市值最高的公司。

On an earnings call in February 2015, Elon Musk, the chairman and chief executive officer (CEO) of Tesla Motors, set out a path for the company to reach a market capitalization of about $700 billion in 10 years.2 That approached the size of Apple Inc., which had the largest market capitalization of any company in the world at the time.

马斯克是这样算的。假设 2015 年销售额为 60 亿美元(目前市场一致预期在 57 亿美元左右),销售额按每年 50% 的速度复合增长,到 2025 年就是约 3450 亿美元。再取 10% 的净利润率,套上 20 倍市盈率,得到的结果非常接近 7000 亿美元。

Here is Musk’s math. If you assume sales in 2015 of $6 billion (the current consensus is around $5.7 billion) and sales growth of 50 percent compounded annually, you get about $345 billion in 2025. If you then take a 10 percent net income margin and apply a price-earnings multiple of 20, you get very close to $700 billion.

显而易见的问题是:特斯拉实现这些数字的可能性有多大?回答这个问题最自然的做法,是撸起袖子自下而上做一遍分析。他们能卖出多少辆车?每辆车成本多少?可以在哪些国家扩大销售?还能进入哪些业务?

The obvious question is: How likely is it that Tesla will achieve those figures? The natural way to answer the question is to roll up your sleeves and do an analysis from the bottom up. How many cars can they sell? How much will each cost? In which countries can they expand sales? What other businesses can they move into?

这门生意的盈利能力会有多强?诸如此类。

How profitable will the business be? And so forth.

研究此类预测的学者发现,两种偏差十分常见:乐观与过度自信。对个人预测抱有乐观态度,有助于人们在困难面前坚持下去,但它会扭曲对可能结果的判断。3 举例来说,尽管新创企业存活五年以上的比例只有约 50%,一项针对数千名创业者的调查却发现,其中超过十分之八的人把自己的成功概率评为 70% 或更高,整整三分之一的人根本不给失败留任何概率。4 关于乐观的结论是:“人们时常认为,自己偏好的结果比实际应有的可能性更大。”5

Researchers who study forecasts of this nature find that two biases, optimism and overconfidence, are common. Optimism about personal predictions has value for encouraging perseverance in the face of challenges, but distorts assessments of likely outcomes.3 For example, notwithstanding that only about 50 percent of new businesses survive five or more years, a survey of thousands of entrepreneurs found that more than 8 of 10 of them rated their odds of success at 70 percent or higher, and fully one-third did not allow for any probability of failure at all.4 The bottom line on optimism: “People frequently believe that their preferred outcomes are more likely than is merited.”5

过度自信偏差同样会削弱人们做出可靠预测的能力。当一个人对自身主观判断的信心,高出客观结果所能支撑的程度时,这种偏差就显现出来。例如,近两千人回答了 50 道判断题,并为每一道题给出信心水平。他们答对的比例约为 60%,但对答案表示的信心却达到 70%。6 包括金融分析师在内,多数人都过分看重自己掌握的信息。7

Overconfidence bias also distorts the ability to make sound predictions. This bias reveals itself when an individual’s confidence in his or her subjective judgments is higher than the objective outcomes warrant. For instance, nearly two thousand people answered 50 true-false questions and provided a confidence level for each. They were correct about 60 percent of the time but indicated confidence in their answers of 70 percent.6 Most people, including financial analysts, place too much weight on their own information.7

过度自信在预测中最典型的表现,是给出的结果区间过窄。有一个恰当的例子:研究者请首席财务官预测股市表现,其中包括他们有 80% 把握认为结果会落入其间的增长率上下限。结果他们只对了三分之一。8

The classic way that overconfidence shows up in forecasts is with ranges of outcomes that are too narrow. As a case in point, researchers asked chief financial officers to predict the results for the stock market, including high and low growth rates within which the executives were 80 percent sure the results would land. They were correct only one-third of the time.8

图表 1 展示了这种偏差在预测中的样貌。两条曲线都是约 1,500 家美国上市公司三年年化销售增长率的分布。9 峰值较低的那条分布反映的是过去二十年的实际结果,峰值较高的那条则是分析师当下预测的增长率集合。

Exhibit 1 shows how this bias manifests in forecasts. Both are distributions of sales growth rates annualized over three years for roughly 1,500 public companies in the U.S.9 The distribution with the lower peak reflects the actual results over the past two decades, and the distribution with the higher peak is the set of growth rates that analysts are currently forecasting.

图表 1:过度自信——销售增长率区间过窄 50 45 基础比率 40 当前预测

Exhibit 1: Overconfidence – Range of Sales Growth Rates Too Narrow 50 45 Base Rates 40 Current Estimates

频率(百分比)

Frequency (Percent)

原件此处是表格,PDF 抽取时列结构已丢失,下面只剩按列读出的数字,行列对应关系无法还原。核对数据请打开来源正文。

35
30
25
20
15
10
 5
 0
   (5)-0   5-10   10-15   15-20   20-25   25-30   30-35   35-40   40-45
   (10)-(5)
   0-5
   <(25)   >45
   (25)-(20)   (20)-(15)   (15)-(10)
35
30
25
20
15
10
 5
 0
   (5)-0   5-10   10-15   15-20   20-25   25-30   30-35   35-40   40-45
   (10)-(5)
   0-5
   <(25)   >45
   (25)-(20)   (20)-(15)   (15)-(10)

3 年销售复合年增长率(百分比)

3-Year Sales CAGR (Percent)

资料来源:FactSet。

Source: FactSet.

注:I/B/E/S 一致预期数据截至 2015 年 5 月 4 日。

Note: I/B/E/S consensus estimates as of May 4, 2015.

与过度自信偏差相一致,预期结果的区间远远窄于历史结果所显示的合理范围。预测通常既过于乐观,又过于狭窄。行为偏差以及激励机制带来的扭曲,是解释这种预测失准模式的最好理由。10

Consistent with the overconfidence bias, the range of expected outcomes is vastly narrower than what the results of the past suggest is reasonable. Forecasts are commonly too optimistic and too narrow. Behavioral biases and distortions introduced by incentives are the best explanations for the pattern of faulty forecasts. 10

有了这些认识,我们该如何评估马斯克那些假设的可信度?一个办法是深入特斯拉的具体情况,设想若干可能的情景。我们甚至可以借助类比:特斯拉拥有颠覆性创新和一位富有活力的领导者,正如苹果一样,而苹果正是特斯拉希望在市值上比肩的公司。

Given these insights, how might we assess the plausibility of Musk’s assumptions? One way would be to delve into the specifics for Tesla and come up with conceivable scenarios. We might even employ an analogy: Tesla has a disruptive innovation and a dynamic leader as did Apple, the company Tesla hopes to match in market capitalization.

但既然知道自己容易乐观、容易过度自信,我们就应该引入一些手段来管住这些偏差。到目前为止最有用的办法,是考察众多公司在长时间里的实际经历,也就是基础比率,再把这个比率与自己的观点审慎地结合起来。这并不是我们惯常的做法。正如著名心理学家丹尼尔·卡尼曼直言不讳地指出的:“掌握了某个具体案例信息的人,很少觉得有必要去了解该案例所属类别的统计数据。”11

But knowing that we are prone to optimism and overconfidence suggests that we should introduce techniques to manage those biases. By far the most useful way to do that is to examine the experience of many companies over time, the base rate, and thoughtfully integrate that rate with our own view. This is not our typical approach. As Daniel Kahneman, the eminent psychologist, notes bluntly, “People who have information about an individual case rarely feel the need to know the statistics of the class to which the case belongs.”11

在评估特斯拉能否实现那些数字时,我们当然可以思考这家公司自身的前景。但按照卡尼曼的思路,我们应该去看所有销售额达到 60 亿美元(经通胀调整)的公司样本,数一数其中有多少家做到了连续十年年均复合增长 50%。过去二十年的答案是:零。事实上,即便把起始销售基数降到 7 亿美元,在 6,700 家公司的总体中也找不到一例以这一速度增长的公司。马斯克虽然承认这些只是假设,但他补充说:“我敢打赌它们会成真。”

We can certainly think about Tesla’s individual prospects in assessing the likelihood that the company will achieve those figures. But Kahneman’s approach would have us look at the sample of all the companies that had $6 billion of sales, adjusted for inflation, to determine how many grew 50 percent compounded annually for ten years. The answer for the past two decades: zero. In fact, if we lower the starting sales base to $700 million, there was not an instance of growth at that rate in a population of 6,700. While Musk allowed that these were assumptions only, he added, “I bet that they do occur.”

尽管决策科学家早就知道,恰当运用基础比率能提升预测质量,这一方法的使用率却低得惊人。12 我们认为这反映了人对叙事的渴求。在讲述具体细节的故事里,因果关系一目了然,情景因此变得生动。基础比率则大体上索然无味,对头脑的吸引力也就小得多。

Though decision scientists have known for a long time that the proper use of base rates improves the quality of forecasts, the technique remains remarkably underused.12 We believe this reflects the human desire for a narrative. Causality is clear in stories about the specifics, which makes those scenarios vivid. Base rates, on the other hand, are largely antiseptic and hence less appealing to the mind.

销售增长的基础比率

Base Rates of Sales Growth

投资者的首要任务,是判断股价所隐含的未来财务表现预期,相对于公司可能实现的表现,究竟是过于乐观还是过于悲观。换句话说,聪明的投资者要寻找预期与基本面之间的落差。13 这种方法并不要求预测精准到点位,只需要判断股价中所嵌入的预期是偏高还是偏低。

An investor’s primary task is to determine whether the expectations for future financial performance, as implied by the stock price, are too optimistic or pessimistic relative to how the company is likely to perform. In other words, the intelligent investor seeks gaps between expectations and fundamentals.13 This approach does not require forecasts of pinpoint accuracy, but rather only judgments as to whether the expectations embedded in the shares are too high or low.

对多数公司而言,销售增长是最重要的价值驱动因素。14 因此,我们分析了标普 1500 指数成分股在 1994 至 2014 年这 21 年间的销售增长率分布。这个样本约占美国股市总市值的 90%。我们在每年年初确定指数成分股,然后为每家公司计算其后 1 年、3 年、5 年、10 年和 20 年的销售复合年增长率(CAGR)。所有销售数据都经过通胀调整,统一折算成 2014 年美元。因此,一家公司在进入标普 1500 之前不会出现在我们的样本里,但一旦进入指数,即便日后被剔除,它仍留在我们的样本中。

Sales growth is the most important driver of corporate value.14 As a result, we analyze the distribution of sales growth rates for the constituents of the S&P 1500 Index over a 21-year period from 1994-2014. This sample represents roughly 90 percent of the capitalization of the U.S. equity market. We identify the members of the index at the beginning of each year and then calculate the compound annual growth rates (CAGR) of sales for the subsequent 1, 3, 5, 10, and 20 years for each firm. We adjust all of the sales figures to remove the effects of inflation, which translates all of the numbers to 2014 dollars. So no company is in our sample until it is included in the S&P 1500, but once it is in the index it stays in our sample even if it exits the index.

图表 2 展示了全样本的结果。左侧面板中,行代表销售增长率,列代表时间区间。假设你想知道,全样本中有多大比例的公司在三年里以 20% 至 25% 的复合年增长率增长。你从标着“20-25”的那一行出发,向右滑到“3 年”那一列,就能看到有 4.4% 的公司达到了这一增长速度。右侧面板给出了每个增长率区间与时间区间对应的样本量,让我们看清这 4.4% 是怎么来的:总数 23,914 例中有 1,060 例(1,060/23,914 = 4.4%)。

Exhibit 2 shows the results for the full sample. In the panel on the left, the rows show sales growth rates and the columns reflect time periods. Say you want to know what percent of the universe grew sales at a CAGR of 20-25 percent for three years. You start with row marked “20-25” and slide to the right to find the column “3- Yr.” There, you’ll see that 4.4 percent of the companies achieved that rate of growth. The panel on the right shows the sample sizes for each growth rate and time period, allowing us to see where the 4.4 percent comes from: 1,060 instances out of the total of 23,914 (1,060/23,914 = 4.4 percent).

图表 2:标普 1500 指数销售增长(CAGR)基础比率(1994-2014)

Exhibit 2: Base Rates of Sales Growth (CAGR) for the S&P 1500 (1994-2014)

原件此处是表格,PDF 抽取时列结构已丢失,下面只剩按列读出的数字,行列对应关系无法还原。核对数据请打开来源正文。

Full Universe   Base Rates   Full Universe   Observations
 CAGR (%)   1-Yr   3-Yr   5-Yr   10-Yr   20-Yr   CAGR (%)   1-Yr  3-Yr   5-Yr 10-Yr 20-Yr
   <(25)   4.0%   1.7% 1.1% 0.5%   0.1%   <(25)   1,153 406   205   56   1
  (25)-(20)   1.6%   1.0% 0.7% 0.1%   0.1%   (25)-(20)   471   246   126   14   1
  (20)-(15)   2.6%   1.8% 1.4% 0.7%   0.1%   (20)-(15)   748   425   261   75   1
  (15)-(10)   3.9%   3.7% 2.9% 1.4%   0.4%   (15)-(10)   1,147 875   564   149   4
   (10)-(5)   7.0%   7.7% 7.0% 5.4%   1.8%   (10)-(5)   2,050 1,842 1,355 574   21
   (5)-0   12.7%   14.7% 16.5% 16.8%   11.5%   (5)-0   3,695 3,508 3,184 1,796 131
   0-5   17.6%   21.6% 24.6% 30.8%   43.0%   0-5   5,138 5,157 4,748 3,285 488
   5-10   15.4%   17.2% 18.7% 23.3%   25.9%   5-10   4,489 4,104 3,606 2,485 294
   10-15   10.6%   11.2% 11.7% 11.7%   11.8%   10-15   3,094 2,689 2,260 1,251 134
   15-20   6.9%   7.0% 6.9% 5.5%   3.9%   15-20   2,004 1,672 1,332 589   44
   20-25   4.7%   4.4% 3.5% 2.0%   0.6%   20-25   1,358 1,060 677   211   7
   25-30   3.2%   2.6% 2.1% 0.7%   0.6%   25-30   929   625   397   80   7
   30-35   2.1%   1.6% 1.0% 0.4%   0.1%   30-35   610   380   192   45   1
   35-40   1.6%   1.2% 0.6% 0.2%   0.2%   35-40   469   282   116   26   2
   40-45   1.2%   0.8% 0.4% 0.2%   0.0%   40-45   349   180   84   18   0
   >45   4.9%   1.9% 0.9% 0.3%   0.0%   >45   1,416 463   181   27   0
   Mean   8.8%   6.2% 5.3% 4.6%   4.9%   Total   29,120 23,914 19,288 10,681 1,136
   Median   5.2%   4.5% 4.2% 4.1%   4.2%
   StDev   50.3%   16.4% 13.1% 9.6%   6.7%
Full Universe   Base Rates   Full Universe   Observations
 CAGR (%)   1-Yr   3-Yr   5-Yr   10-Yr   20-Yr   CAGR (%)   1-Yr  3-Yr   5-Yr 10-Yr 20-Yr
   <(25)   4.0%   1.7% 1.1% 0.5%   0.1%   <(25)   1,153 406   205   56   1
  (25)-(20)   1.6%   1.0% 0.7% 0.1%   0.1%   (25)-(20)   471   246   126   14   1
  (20)-(15)   2.6%   1.8% 1.4% 0.7%   0.1%   (20)-(15)   748   425   261   75   1
  (15)-(10)   3.9%   3.7% 2.9% 1.4%   0.4%   (15)-(10)   1,147 875   564   149   4
   (10)-(5)   7.0%   7.7% 7.0% 5.4%   1.8%   (10)-(5)   2,050 1,842 1,355 574   21
   (5)-0   12.7%   14.7% 16.5% 16.8%   11.5%   (5)-0   3,695 3,508 3,184 1,796 131
   0-5   17.6%   21.6% 24.6% 30.8%   43.0%   0-5   5,138 5,157 4,748 3,285 488
   5-10   15.4%   17.2% 18.7% 23.3%   25.9%   5-10   4,489 4,104 3,606 2,485 294
   10-15   10.6%   11.2% 11.7% 11.7%   11.8%   10-15   3,094 2,689 2,260 1,251 134
   15-20   6.9%   7.0% 6.9% 5.5%   3.9%   15-20   2,004 1,672 1,332 589   44
   20-25   4.7%   4.4% 3.5% 2.0%   0.6%   20-25   1,358 1,060 677   211   7
   25-30   3.2%   2.6% 2.1% 0.7%   0.6%   25-30   929   625   397   80   7
   30-35   2.1%   1.6% 1.0% 0.4%   0.1%   30-35   610   380   192   45   1
   35-40   1.6%   1.2% 0.6% 0.2%   0.2%   35-40   469   282   116   26   2
   40-45   1.2%   0.8% 0.4% 0.2%   0.0%   40-45   349   180   84   18   0
   >45   4.9%   1.9% 0.9% 0.3%   0.0%   >45   1,416 463   181   27   0
   Mean   8.8%   6.2% 5.3% 4.6%   4.9%   Total   29,120 23,914 19,288 10,681 1,136
   Median   5.2%   4.5% 4.2% 4.1%   4.2%
   StDev   50.3%   16.4% 13.1% 9.6%   6.7%

资料来源:FactSet。

Source: FactSet.

注:CAGR = 复合年增长率。

Note: CAGR = compound annual growth rate.

图表 3 是三年销售增长率的分布。它用图形呈现了图表 2 中数字所说的内容。均值增长率为每年 6.2%,中位数增长率为 4.5%。由于分布右偏,中位数更能代表结果的集中位置。标准差为 16.4%,反映了这条钟形曲线的宽度。

Exhibit 3 is the distribution for the three-year sales growth rate. This shows, in a graph, what the numbers say in exhibit 2. The mean, or average, growth rate was 6.2 percent per year and the median growth rate was 4.5 percent. The median is a better indicator of the central location of the results because the distribution is skewed to the right. The standard deviation, 16.4 percent, gives an indication of the width of the bell curve.

图表 3:标普 1500 指数三年销售复合年增长率(1994-2014)

Exhibit 3: Three-Year CAGR of Sales for the S&P 1500 (1994-2014)

25

25

20

20

频率(百分比)

Frequency (Percent)

原件此处是表格,PDF 抽取时列结构已丢失,下面只剩按列读出的数字,行列对应关系无法还原。核对数据请打开来源正文。

15
10
 5
 0
   (5)-0   5-10   10-15   15-20   20-25   25-30   30-35   35-40   40-45
   (10)-(5)
   <(25)
   0-5   >45
   (25)-(20)   (20)-(15)   (15)-(10)
15
10
 5
 0
   (5)-0   5-10   10-15   15-20   20-25   25-30   30-35   35-40   40-45
   (10)-(5)
   <(25)
   0-5   >45
   (25)-(20)   (20)-(15)   (15)-(10)

复合年增长率(百分比)

CAGR (Percent)

资料来源:FactSet。

Source: FactSet.

注:CAGR = 复合年增长率。

Note: CAGR = compound annual growth rate.

全样本数据只是一个起点,我们还想把基础比率的参照类别收窄,让结果更贴切、更有用。最好的办法,是按公司上一年的销售额把全样本分成十分位。在每个规模十分位内部,我们再把增长率观测值按 5 个百分点的间隔分箱(两端的尾部除外)。样本中也包括如今已经消失的公司。15

While the data for the full sample are a start, we want to sharpen the reference class of base rates to make the results more relevant and applicable. The best way to do that is to break the universe into deciles based on a company’s sales in the prior year. Within each size decile, we sort the observations of growth rates into bins in increments of 5 percentage points (except for the tails). The population includes companies that are now dead.15

由于每个样本只包含在相应时段里存活下来的公司,这里存在一定程度的幸存者偏差。比如,一家公司要进入我们的 20 年样本,就必须存活 20 年。为了让你对这一影响有个直观感受:1 年的存活率为 92%,3 年为 84%,5 年为 76%,10 年为 59%,20 年为 38%。

There is a modest survivorship bias because each sample only includes the firms that survived for that specified time. For a company to be included in our 20-year sample, for instance, requires 20 years of survival. To give you some sense of this effect, the survivorship rates are 92 percent for 1 year, 84 percent for 3 years, 76 percent for 5 years, 59 percent for 10 years, and 38 percent for 20 years.

本文分析的核心是图表 4,它列出了每个十分位、全部总体,以及对超大型公司(销售额超过 500 亿美元)的额外分析。使用方法如下。先确定你想建模的那家公司的销售基数,再根据这一规模找到对应的十分位。

The heart of this analysis is exhibit 4, which shows each decile, the total population, and an additional analysis of mega companies (those with sales in excess of $50 billion). Here’s how you use the exhibit. Determine the base sales level for the company that you want to model. Then go to the appropriate decile based on that size.

这样你就得到了恰当的参照类别,以及不同时间跨度下的增长率分布。

You now have the proper reference class and the distribution of growth rates for the various time horizons.

我们以特斯拉为例。埃隆·马斯克说,他希望在未来十年里,从 60 亿美元的销售基数出发,每年把销售额提高 50%。我们先找到正确的参照类别。在这个例子里,就是销售基数介于 60 亿至 130 亿美元的那个十分位。接着我们查看标着“>45”的那一行,它代表 45% 及以上的销售增长率。顺着“10 年”那一列往下看,会发现没有任何一家公司做到这一点。事实上,我们得一路下降到 35% 至 40% 的增长区间才看得到公司,而即便在那里,也只占样本的千分之二。

Let’s use Tesla as an example. Elon Musk said he hopes to grow sales 50 percent per year for the next decade from a sales base of $6 billion. We first find the correct reference class. In this case, it’s the decile that has a sales base between $6 and 13 billion. Next we examine the row of growth that is marked “>45,” representing a sales growth rate of 45 percent or more. Going out to the column under “10-Yr,” we see that no companies achieved this feat. Indeed, we have to go down to 35-40 percent growth to see any companies, and even there it is only one-fifth of 1 percent of the sample.

总体而言,图表 4 给出了 55 个参照类别的结果(11 个规模区间乘以 5 个时间跨度),足以覆盖销售增长绝大多数可能的结果。附录列出了每个参照类别的样本量。稍后我们会说明如何把这些基础比率纳入你自己的销售增长预测,但眼下值得先承认:这批数据既是有用的分析指引,也是宝贵的现实检验。

In total, exhibit 4 shows results for 55 reference classes (11 size ranges times 5 time horizons) that should cover the vast majority of possible outcomes for sales growth. The appendix contains the sample sizes for each of the reference classes. We will show how to incorporate these base rates into your forecasts for sales growth in a moment, but for now it’s useful to acknowledge the utility of these data as an analytical guide and a valuable reality check.

图表 4:标普 1500 指数按十分位划分的基础比率(1994-2014)

Exhibit 4: Base Rates by Decile for S&P 1500 (1994-2014)

原件此处是表格,PDF 抽取时列结构已丢失,下面只剩按列读出的数字,行列对应关系无法还原。核对数据请打开来源正文。

  $0-250 Mn   Base Rates   $250-450 Mn   Base Rates   $450-700 Mn   Base Rates
  CAGR (%)   1-Yr   3-Yr   5-Yr   10-Yr   20-Yr   CAGR (%)   1-Yr   3-Yr   5-Yr   10-Yr 20-Yr   CAGR (%)   1-Yr   3-Yr   5-Yr   10-Yr 20-Yr
   <(25)   6.6%   4.1% 4.0% 2.7%   0.8%   <(25)   4.1%   1.6% 0.9% 0.2% 0.0%   <(25)   3.9%   1.4% 0.5% 0.2% 0.0%
  (25)-(20)   2.2%   1.4% 0.7% 0.2%   0.0%   (25)-(20)   1.6%   0.8% 0.6% 0.1% 0.0%   (25)-(20)   1.6%   1.1% 0.2% 0.0% 0.0%
  (20)-(15)   2.6%   1.8% 1.3% 1.9%   0.0%   (20)-(15)   2.9%   1.9% 1.0% 0.2% 0.0%   (20)-(15)   2.8%   2.1% 2.1% 0.2% 0.0%
  (15)-(10)   3.8%   3.2% 2.2% 1.0%   0.0%   (15)-(10)   3.3%   3.2% 3.0% 0.8% 0.0%   (15)-(10)   4.5%   3.7% 3.4% 1.9% 0.0%
   (10)-(5)   6.0%   6.4% 4.6% 2.0%   1.6%   (10)-(5)   6.1%   5.6% 5.5% 4.0% 0.0%   (10)-(5)   6.5%   7.8% 6.0% 6.7% 0.0%
   (5)-0   8.8%   9.1% 10.5% 7.4%   4.0%   (5)-0   10.8%   9.8% 11.0% 15.7% 4.6%   (5)-0   10.3%   10.7% 12.8% 13.5% 7.3%
   0-5   11.0%   12.9% 14.7% 18.1%   17.7%   0-5   13.4%   17.1% 19.3% 22.1% 34.5%   0-5   14.4%   17.3% 19.4% 25.6% 34.9%
   5-10   10.4%   12.5% 15.5% 20.9%   26.6%   5-10   12.6%   16.6% 19.3% 23.8% 29.9%   5-10   15.0%   18.2% 20.0% 26.0% 29.4%
   10-15   9.3%   11.2% 12.1% 15.8%   25.0%   10-15   11.6%   14.6% 16.3% 16.4% 23.0%   10-15   11.2%   13.1% 16.1% 16.0% 23.9%
   15-20   7.4%   8.2% 11.3% 11.0%   14.5%   15-20   8.4%   8.5% 9.2% 9.7% 6.9%   15-20   7.7%   9.6% 9.0% 6.0% 3.7%
   20-25   5.1%   7.4% 5.6% 7.7%   2.4%   20-25   6.2%   7.2% 5.6% 4.4% 1.1%   20-25   5.5%   6.5% 4.5% 2.0% 0.0%
   25-30   4.6%   5.3% 4.8% 3.3%   4.8%   25-30   4.5%   4.4% 3.6% 1.1% 0.0%   25-30   4.5%   2.5% 3.1% 0.7% 0.9%
   30-35   3.7%   3.3% 3.3% 2.2%   0.8%   30-35   2.6%   2.3% 1.6% 0.2% 0.0%   30-35   3.1%   1.7% 0.8% 0.6% 0.0%
   35-40   2.9%   3.0% 2.3% 1.1%   1.6%   35-40   2.8%   1.7% 1.1% 0.5% 0.0%   35-40   1.9%   1.3% 0.8% 0.3% 0.0%
   40-45   2.5%   2.0% 1.4% 1.5%   0.0%   40-45   2.3%   1.6% 1.0% 0.5% 0.0%   40-45   1.5%   0.9% 0.4% 0.1% 0.0%
   >45   12.9%   8.2% 5.8% 3.1%   0.0%   >45   6.9%   3.2% 1.0% 0.1% 0.0%   >45   5.6%   2.1% 0.8% 0.1% 0.0%
   Mean   24.1%   13.3% 10.9% 9.9%   9.9%   Mean   11.2%   9.6% 8.1% 6.9% 7.5%   Mean   10.0%   7.7% 6.9% 5.5% 6.7%
   Median   9.1%   9.5% 8.8% 8.8%   9.8%   Median   8.3%   7.9% 7.1% 6.1% 6.7%   Median   6.9%   6.7% 6.3% 5.4% 6.9%
   StDev   153.9%   30.6% 24.2% 18.1%   12.8%   StDev   25.9%   17.4% 13.9% 9.5% 5.2%   StDev   28.4%   16.0% 12.3% 8.9% 5.3%
$700-1,000 Mn   Base Rates   $1,000-1,500 Mn   Base Rates   $1,500-2,250 Mn   Base Rates
  CAGR (%)   1-Yr   3-Yr   5-Yr   10-Yr 20-Yr   CAGR (%)   1-Yr   3-Yr   5-Yr   10-Yr 20-Yr   CAGR (%)   1-Yr   3-Yr   5-Yr   10-Yr   20-Yr
   <(25)   3.4%   1.3% 0.2% 0.3% 0.0%   <(25)   3.5%   1.1% 0.8% 0.7% 0.0%   <(25)   3.3%   1.2% 0.5% 0.2%   0.0%
  (25)-(20)   1.6%   1.4% 1.0% 0.0% 0.0%   (25)-(20)   1.7%   0.7% 0.4% 0.1% 0.0%   (25)-(20)   1.9%   1.0% 0.6% 0.3%   0.0%
  (20)-(15)   2.6%   1.2% 1.0% 1.1% 0.0%   (20)-(15)   2.8%   2.0% 1.0% 0.5% 1.0%   (20)-(15)   2.4%   1.9% 1.2% 0.3%   0.0%
  (15)-(10)   4.2%   3.9% 2.6% 1.4% 1.8%   (15)-(10)   4.1%   3.5% 2.5% 0.6% 0.0%   (15)-(10)   4.1%   3.7% 2.8% 0.9%   0.9%
   (10)-(5)   7.4%   8.5% 7.3% 3.2% 1.8%   (10)-(5)   7.3%   8.4% 8.1% 3.0% 0.0%   (10)-(5)   6.8%   7.3% 6.6% 7.7%   2.6%
   (5)-0   12.8%   13.6% 15.4% 12.9% 6.3%   (5)-0   12.3%   15.3% 17.3% 17.6% 7.9%   (5)-0   12.8%   14.7% 17.3% 14.6%   11.1%
   0-5   16.2%   20.7% 24.9% 31.0% 39.6%   0-5   16.9%   20.8% 22.5% 29.2% 53.5%   0-5   18.4%   22.7% 25.3% 35.0%   48.7%
   5-10   15.4%   16.0% 17.4% 22.2% 34.2%   42134   15.8%   15.9% 19.2% 28.6% 26.7%   5-10   15.6%   19.1% 21.6% 23.8%   19.7%
   10-15   9.9%   12.1% 13.1% 15.5% 9.9%   42292   11.5%   13.0% 13.5% 12.0% 8.9%   10-15   12.2%   12.2% 11.6% 10.3%   13.7%
   15-20   8.3%   8.7% 8.3% 7.9% 5.4%   15-20   6.9%   8.0% 7.5% 5.5% 2.0%   15-20   6.9%   6.7% 6.3% 4.8%   2.6%
   20-25   5.0%   4.6% 4.1% 2.4% 0.9%   20-25   5.3%   4.2% 3.2% 1.1% 0.0%   20-25   4.6%   3.4% 3.2% 1.2%   0.9%
   25-30   3.5%   2.9% 2.1% 1.0% 0.0%   25-30   3.4%   2.3% 1.6% 0.8% 0.0%   25-30   2.8%   2.3% 1.4% 0.5%   0.0%
   30-35   2.5%   2.1% 0.8% 0.8% 0.0%   30-35   2.0%   1.5% 0.9% 0.2% 0.0%   30-35   1.9%   1.0% 0.6% 0.3%   0.0%
   35-40   1.8%   1.4% 0.6% 0.2% 0.0%   35-40   1.3%   0.9% 0.4% 0.1% 0.0%   35-40   1.7%   0.8% 0.3% 0.1%   0.0%
   40-45   1.1%   0.3% 0.3% 0.0% 0.0%   40-45   1.0%   0.7% 0.4% 0.0% 0.0%   40-45   1.0%   0.5% 0.3% 0.1%   0.0%
   >45   4.4%   1.3% 0.9% 0.0% 0.0%   >45   4.3%   1.5% 0.6% 0.0% 0.0%   >45   3.9%   1.5% 0.4% 0.0%   0.0%
   Mean   9.0%   6.5% 5.9% 5.7% 5.1%   Mean   7.8%   6.0% 5.0% 4.6% 4.3%   Mean   7.5%   5.5% 4.8% 4.1%   4.3%
   Median   5.6%   4.9% 4.5% 5.0% 5.0%   Median   5.4%   4.6% 4.4% 4.7% 4.1%   Median   5.2%   4.5% 4.2% 3.6%   3.1%
   StDev   33.3%   15.2% 11.8% 9.4% 5.6%   StDev   23.9%   15.1% 12.9% 9.5% 4.5%   StDev   22.9%   13.4% 10.4% 7.2%   5.5%
  $0-250 Mn   Base Rates   $250-450 Mn   Base Rates   $450-700 Mn   Base Rates
  CAGR (%)   1-Yr   3-Yr   5-Yr   10-Yr   20-Yr   CAGR (%)   1-Yr   3-Yr   5-Yr   10-Yr 20-Yr   CAGR (%)   1-Yr   3-Yr   5-Yr   10-Yr 20-Yr
   <(25)   6.6%   4.1% 4.0% 2.7%   0.8%   <(25)   4.1%   1.6% 0.9% 0.2% 0.0%   <(25)   3.9%   1.4% 0.5% 0.2% 0.0%
  (25)-(20)   2.2%   1.4% 0.7% 0.2%   0.0%   (25)-(20)   1.6%   0.8% 0.6% 0.1% 0.0%   (25)-(20)   1.6%   1.1% 0.2% 0.0% 0.0%
  (20)-(15)   2.6%   1.8% 1.3% 1.9%   0.0%   (20)-(15)   2.9%   1.9% 1.0% 0.2% 0.0%   (20)-(15)   2.8%   2.1% 2.1% 0.2% 0.0%
  (15)-(10)   3.8%   3.2% 2.2% 1.0%   0.0%   (15)-(10)   3.3%   3.2% 3.0% 0.8% 0.0%   (15)-(10)   4.5%   3.7% 3.4% 1.9% 0.0%
   (10)-(5)   6.0%   6.4% 4.6% 2.0%   1.6%   (10)-(5)   6.1%   5.6% 5.5% 4.0% 0.0%   (10)-(5)   6.5%   7.8% 6.0% 6.7% 0.0%
   (5)-0   8.8%   9.1% 10.5% 7.4%   4.0%   (5)-0   10.8%   9.8% 11.0% 15.7% 4.6%   (5)-0   10.3%   10.7% 12.8% 13.5% 7.3%
   0-5   11.0%   12.9% 14.7% 18.1%   17.7%   0-5   13.4%   17.1% 19.3% 22.1% 34.5%   0-5   14.4%   17.3% 19.4% 25.6% 34.9%
   5-10   10.4%   12.5% 15.5% 20.9%   26.6%   5-10   12.6%   16.6% 19.3% 23.8% 29.9%   5-10   15.0%   18.2% 20.0% 26.0% 29.4%
   10-15   9.3%   11.2% 12.1% 15.8%   25.0%   10-15   11.6%   14.6% 16.3% 16.4% 23.0%   10-15   11.2%   13.1% 16.1% 16.0% 23.9%
   15-20   7.4%   8.2% 11.3% 11.0%   14.5%   15-20   8.4%   8.5% 9.2% 9.7% 6.9%   15-20   7.7%   9.6% 9.0% 6.0% 3.7%
   20-25   5.1%   7.4% 5.6% 7.7%   2.4%   20-25   6.2%   7.2% 5.6% 4.4% 1.1%   20-25   5.5%   6.5% 4.5% 2.0% 0.0%
   25-30   4.6%   5.3% 4.8% 3.3%   4.8%   25-30   4.5%   4.4% 3.6% 1.1% 0.0%   25-30   4.5%   2.5% 3.1% 0.7% 0.9%
   30-35   3.7%   3.3% 3.3% 2.2%   0.8%   30-35   2.6%   2.3% 1.6% 0.2% 0.0%   30-35   3.1%   1.7% 0.8% 0.6% 0.0%
   35-40   2.9%   3.0% 2.3% 1.1%   1.6%   35-40   2.8%   1.7% 1.1% 0.5% 0.0%   35-40   1.9%   1.3% 0.8% 0.3% 0.0%
   40-45   2.5%   2.0% 1.4% 1.5%   0.0%   40-45   2.3%   1.6% 1.0% 0.5% 0.0%   40-45   1.5%   0.9% 0.4% 0.1% 0.0%
   >45   12.9%   8.2% 5.8% 3.1%   0.0%   >45   6.9%   3.2% 1.0% 0.1% 0.0%   >45   5.6%   2.1% 0.8% 0.1% 0.0%
   Mean   24.1%   13.3% 10.9% 9.9%   9.9%   Mean   11.2%   9.6% 8.1% 6.9% 7.5%   Mean   10.0%   7.7% 6.9% 5.5% 6.7%
   Median   9.1%   9.5% 8.8% 8.8%   9.8%   Median   8.3%   7.9% 7.1% 6.1% 6.7%   Median   6.9%   6.7% 6.3% 5.4% 6.9%
   StDev   153.9%   30.6% 24.2% 18.1%   12.8%   StDev   25.9%   17.4% 13.9% 9.5% 5.2%   StDev   28.4%   16.0% 12.3% 8.9% 5.3%
$700-1,000 Mn   Base Rates   $1,000-1,500 Mn   Base Rates   $1,500-2,250 Mn   Base Rates
  CAGR (%)   1-Yr   3-Yr   5-Yr   10-Yr 20-Yr   CAGR (%)   1-Yr   3-Yr   5-Yr   10-Yr 20-Yr   CAGR (%)   1-Yr   3-Yr   5-Yr   10-Yr   20-Yr
   <(25)   3.4%   1.3% 0.2% 0.3% 0.0%   <(25)   3.5%   1.1% 0.8% 0.7% 0.0%   <(25)   3.3%   1.2% 0.5% 0.2%   0.0%
  (25)-(20)   1.6%   1.4% 1.0% 0.0% 0.0%   (25)-(20)   1.7%   0.7% 0.4% 0.1% 0.0%   (25)-(20)   1.9%   1.0% 0.6% 0.3%   0.0%
  (20)-(15)   2.6%   1.2% 1.0% 1.1% 0.0%   (20)-(15)   2.8%   2.0% 1.0% 0.5% 1.0%   (20)-(15)   2.4%   1.9% 1.2% 0.3%   0.0%
  (15)-(10)   4.2%   3.9% 2.6% 1.4% 1.8%   (15)-(10)   4.1%   3.5% 2.5% 0.6% 0.0%   (15)-(10)   4.1%   3.7% 2.8% 0.9%   0.9%
   (10)-(5)   7.4%   8.5% 7.3% 3.2% 1.8%   (10)-(5)   7.3%   8.4% 8.1% 3.0% 0.0%   (10)-(5)   6.8%   7.3% 6.6% 7.7%   2.6%
   (5)-0   12.8%   13.6% 15.4% 12.9% 6.3%   (5)-0   12.3%   15.3% 17.3% 17.6% 7.9%   (5)-0   12.8%   14.7% 17.3% 14.6%   11.1%
   0-5   16.2%   20.7% 24.9% 31.0% 39.6%   0-5   16.9%   20.8% 22.5% 29.2% 53.5%   0-5   18.4%   22.7% 25.3% 35.0%   48.7%
   5-10   15.4%   16.0% 17.4% 22.2% 34.2%   42134   15.8%   15.9% 19.2% 28.6% 26.7%   5-10   15.6%   19.1% 21.6% 23.8%   19.7%
   10-15   9.9%   12.1% 13.1% 15.5% 9.9%   42292   11.5%   13.0% 13.5% 12.0% 8.9%   10-15   12.2%   12.2% 11.6% 10.3%   13.7%
   15-20   8.3%   8.7% 8.3% 7.9% 5.4%   15-20   6.9%   8.0% 7.5% 5.5% 2.0%   15-20   6.9%   6.7% 6.3% 4.8%   2.6%
   20-25   5.0%   4.6% 4.1% 2.4% 0.9%   20-25   5.3%   4.2% 3.2% 1.1% 0.0%   20-25   4.6%   3.4% 3.2% 1.2%   0.9%
   25-30   3.5%   2.9% 2.1% 1.0% 0.0%   25-30   3.4%   2.3% 1.6% 0.8% 0.0%   25-30   2.8%   2.3% 1.4% 0.5%   0.0%
   30-35   2.5%   2.1% 0.8% 0.8% 0.0%   30-35   2.0%   1.5% 0.9% 0.2% 0.0%   30-35   1.9%   1.0% 0.6% 0.3%   0.0%
   35-40   1.8%   1.4% 0.6% 0.2% 0.0%   35-40   1.3%   0.9% 0.4% 0.1% 0.0%   35-40   1.7%   0.8% 0.3% 0.1%   0.0%
   40-45   1.1%   0.3% 0.3% 0.0% 0.0%   40-45   1.0%   0.7% 0.4% 0.0% 0.0%   40-45   1.0%   0.5% 0.3% 0.1%   0.0%
   >45   4.4%   1.3% 0.9% 0.0% 0.0%   >45   4.3%   1.5% 0.6% 0.0% 0.0%   >45   3.9%   1.5% 0.4% 0.0%   0.0%
   Mean   9.0%   6.5% 5.9% 5.7% 5.1%   Mean   7.8%   6.0% 5.0% 4.6% 4.3%   Mean   7.5%   5.5% 4.8% 4.1%   4.3%
   Median   5.6%   4.9% 4.5% 5.0% 5.0%   Median   5.4%   4.6% 4.4% 4.7% 4.1%   Median   5.2%   4.5% 4.2% 3.6%   3.1%
   StDev   33.3%   15.2% 11.8% 9.4% 5.6%   StDev   23.9%   15.1% 12.9% 9.5% 4.5%   StDev   22.9%   13.4% 10.4% 7.2%   5.5%

原件此处是表格,PDF 抽取时列结构已丢失,下面只剩按列读出的数字,行列对应关系无法还原。核对数据请打开来源正文。

$2,250-3,500 Mn   Base Rates   $3,500-6,000 Mn   Base Rates   $6,000-13,000 Mn   Base Rates
   CAGR (%)   1-Yr   3-Yr   5-Yr   10-Yr 20-Yr   CAGR (%)   1-Yr   3-Yr   5-Yr   10-Yr 20-Yr   CAGR (%)   1-Yr   3-Yr   5-Yr   10-Yr 20-Yr
   <(25)   3.8%   1.6% 0.6% 0.7% 0.0%   <(25)   3.7%   1.4% 0.9% 0.3% 0.0%   <(25)   4.1%   1.6% 1.3% 0.2% 0.0%
   (25)-(20)   1.5%   1.0% 0.4% 0.3% 1.0%   (25)-(20)   1.3%   1.0% 0.8% 0.1% 0.0%   (25)-(20)   1.7%   1.2% 0.7% 0.0% 0.0%
   (20)-(15)   2.8%   2.0% 2.0% 0.4% 0.0%   (20)-(15)   2.2%   1.5% 1.4% 0.7% 0.0%   (20)-(15)   2.6%   1.7% 1.1% 1.0% 0.0%
   (15)-(10)   3.8%   4.0% 3.4% 1.9% 1.0%   (15)-(10)   4.3%   3.9% 3.1% 1.0% 0.0%   (15)-(10)   3.7%   4.1% 3.2% 1.4% 0.0%
   (10)-(5)   6.5%   7.6% 8.4% 6.6% 3.0%   (10)-(5)   7.3%   7.6% 6.9% 6.4% 1.9%   (10)-(5)   7.5%   9.1% 8.2% 6.0% 2.1%
   (5)-0   12.8%   15.2% 16.7% 19.6% 14.0%   (5)-0   13.7%   16.5% 17.9% 19.1% 17.0%   (5)-0   14.0%   18.1% 21.6% 21.7% 13.4%
   0-5   20.5%   24.8% 26.6% 31.6% 55.0%   0-5   20.4%   24.4% 28.8% 36.2% 44.3%   0-5   20.3%   24.3% 27.6% 36.8% 59.2%
   5-10   16.2%   16.9% 17.9% 22.3% 17.0%   5-10   17.3%   18.9% 18.7% 20.3% 33.0%   5-10   17.2%   17.5% 18.6% 22.3% 19.7%
   10-15   10.9%   11.1% 11.8% 8.9% 5.0%   10-15   10.4%   9.8% 8.3% 11.8% 1.9%   10-15   10.8%   9.1% 8.8% 6.6% 5.6%
   15-20   7.0%   6.5% 5.9% 5.3% 3.0%   15-20   6.3%   5.7% 6.1% 3.3% 1.9%   15-20   5.5%   5.4% 4.5% 2.6% 0.0%
   20-25   4.2%   3.4% 2.9% 1.6% 1.0%   20-25   4.0%   3.2% 3.7% 0.4% 0.0%   20-25   3.9%   3.3% 1.7% 0.9% 0.0%
   25-30   2.8%   2.4% 1.5% 0.4% 0.0%   25-30   2.2%   1.6% 1.7% 0.4% 0.0%   25-30   2.3%   1.9% 1.7% 0.1% 0.0%
   30-35   1.5%   1.3% 0.9% 0.1% 0.0%   30-35   1.4%   1.7% 0.7% 0.0% 0.0%   30-35   1.5%   0.8% 0.4% 0.3% 0.0%
   35-40   1.4%   0.9% 0.4% 0.3% 0.0%   35-40   1.1%   1.1% 0.3% 0.1% 0.0%   35-40   1.0%   0.8% 0.3% 0.2% 0.0%
   40-45   0.9%   0.4% 0.5% 0.0% 0.0%   40-45   0.8%   0.8% 0.2% 0.0% 0.0%   40-45   0.7%   0.2% 0.2% 0.0% 0.0%
   >45   3.4%   0.9% 0.4% 0.0% 0.0%   >45   3.6%   1.0% 0.4% 0.0% 0.0%   >45   3.4%   0.8% 0.2% 0.0% 0.0%
   Mean   6.3%   4.7% 4.1% 3.4% 3.1%   Mean   6.1%   4.9% 4.1% 3.3% 3.6%   Mean   5.5%   3.5% 3.0% 2.8% 3.1%
   Median   4.5%   3.8% 3.4% 3.3% 2.9%   Median   4.3%   3.6% 3.4% 3.0% 3.8%   Median   4.1%   2.9% 2.7% 2.9% 2.6%
   StDev   20.7%   13.1% 11.7% 9.4% 5.8%   StDev   21.5%   13.3% 10.7% 6.8% 4.3%   StDev   21.5%   12.7% 10.1% 7.3% 3.8%
  >$13,000 Mn   Base Rates   >$50,000 Mn   Base Rates   Full Universe   Base Rates
   CAGR (%)   1-Yr   3-Yr   5-Yr   10-Yr 20-Yr   CAGR (%)   1-Yr   3-Yr   5-Yr   10-Yr   20-Yr   CAGR (%)   1-Yr   3-Yr   5-Yr   10-Yr   20-Yr
   <(25)   3.8%   2.2% 1.4% 0.2% 0.0%   <(25)   4.4%   3.1% 3.6% 0.5%   0.0%   <(25)   4.0%   1.7% 1.1% 0.5%   0.1%
   (25)-(20)   1.3%   0.9% 1.2% 0.2% 0.0%   (25)-(20)   1.1%   0.9% 0.9% 0.5%   0.0%   (25)-(20)   1.6%   1.0% 0.7% 0.1%   0.1%
   (20)-(15)   2.2%   1.7% 1.5% 1.0% 0.0%   (20)-(15)   2.0%   1.6% 1.1% 0.9%   0.0%   (20)-(15)   2.6%   1.8% 1.4% 0.7%   0.1%
   (15)-(10)   3.6%   3.3% 2.8% 2.6% 0.0%   (15)-(10)   4.1%   3.6% 2.3% 5.7%   0.0%   (15)-(10)   3.9%   3.7% 2.9% 1.4%   0.4%
   (10)-(5)   8.6%   8.1% 7.5% 6.6% 4.6%   (10)-(5)   9.9%   9.5% 7.7% 4.7%   12.5%   (10)-(5)   7.0%   7.7% 7.0% 5.4%   1.8%
   (5)-0   17.1%   20.5% 20.7% 21.3% 26.9%   (5)-0   16.5%   20.9% 22.0% 23.1%   25.0%   (5)-0   12.7%   14.7% 16.5% 16.8%   11.5%
   0-5   22.3%   26.6% 31.5% 33.9% 36.9%   0-5   23.3%   28.2% 33.6% 34.9%   43.8%   0-5   17.6%   21.6% 24.6% 30.8%   43.0%
   5-10   17.2%   18.8% 18.2% 22.3% 26.9%   5-10   18.0%   19.5% 17.9% 25.9%   18.8%   5-10   15.4%   17.2% 18.7% 23.3%   25.9%
   10-15   8.7%   7.4% 7.9% 8.4% 4.6%   10-15   7.7%   6.6% 7.7% 3.3%   0.0%   10-15   10.6%   11.2% 11.7% 11.7%   11.8%
   15-20   5.1%   3.9% 3.5% 2.6% 0.0%   15-20   4.5%   2.9% 1.8% 0.5%   0.0%   15-20   6.9%   7.0% 6.9% 5.5%   3.9%
   20-25   3.3%   2.5% 2.1% 0.6% 0.0%   20-25   3.5%   1.6% 0.9% 0.0%   0.0%   20-25   4.7%   4.4% 3.5% 2.0%   0.6%
   25-30   2.0%   1.4% 0.6% 0.2% 0.0%   25-30   1.7%   0.5% 0.5% 0.0%   0.0%   25-30   3.2%   2.6% 2.1% 0.7%   0.6%
   30-35   1.1%   0.9% 0.7% 0.1% 0.0%   30-35   0.8%   0.2% 0.0% 0.0%   0.0%   30-35   2.1%   1.6% 1.0% 0.4%   0.1%
   35-40   0.8%   0.6% 0.2% 0.0% 0.0%   35-40   0.6%   0.4% 0.0% 0.0%   0.0%   35-40   1.6%   1.2% 0.6% 0.2%   0.2%
   40-45   0.6%   0.4% 0.1% 0.0% 0.0%   40-45   0.2%   0.2% 0.0% 0.0%   0.0%   40-45   1.2%   0.8% 0.4% 0.2%   0.0%
   >45   2.4%   0.7% 0.2% 0.0% 0.0%   >45   2.0%   0.2% 0.0% 0.0%   0.0%   >45   4.9%   1.9% 0.9% 0.3%   0.0%
   Mean   4.1%   2.8% 2.5% 2.6% 2.5%   Mean   2.4%   1.0% 1.0% 1.2%   1.2%   Mean   8.8%   6.2% 5.3% 4.6%   4.9%
   Median   3.0%   2.3% 2.2% 2.7% 2.6%   Median   2.6%   1.8% 1.7% 2.0%   0.6%   Median   5.2%   4.5% 4.2% 4.1%   4.2%
   StDev   18.6%   12.1% 9.8% 7.0% 4.7%   StDev   18.6%   11.6% 9.4% 6.5%   4.4%   StDev   50.3%   16.4% 13.1% 9.6%   6.7%
$2,250-3,500 Mn   Base Rates   $3,500-6,000 Mn   Base Rates   $6,000-13,000 Mn   Base Rates
   CAGR (%)   1-Yr   3-Yr   5-Yr   10-Yr 20-Yr   CAGR (%)   1-Yr   3-Yr   5-Yr   10-Yr 20-Yr   CAGR (%)   1-Yr   3-Yr   5-Yr   10-Yr 20-Yr
   <(25)   3.8%   1.6% 0.6% 0.7% 0.0%   <(25)   3.7%   1.4% 0.9% 0.3% 0.0%   <(25)   4.1%   1.6% 1.3% 0.2% 0.0%
   (25)-(20)   1.5%   1.0% 0.4% 0.3% 1.0%   (25)-(20)   1.3%   1.0% 0.8% 0.1% 0.0%   (25)-(20)   1.7%   1.2% 0.7% 0.0% 0.0%
   (20)-(15)   2.8%   2.0% 2.0% 0.4% 0.0%   (20)-(15)   2.2%   1.5% 1.4% 0.7% 0.0%   (20)-(15)   2.6%   1.7% 1.1% 1.0% 0.0%
   (15)-(10)   3.8%   4.0% 3.4% 1.9% 1.0%   (15)-(10)   4.3%   3.9% 3.1% 1.0% 0.0%   (15)-(10)   3.7%   4.1% 3.2% 1.4% 0.0%
   (10)-(5)   6.5%   7.6% 8.4% 6.6% 3.0%   (10)-(5)   7.3%   7.6% 6.9% 6.4% 1.9%   (10)-(5)   7.5%   9.1% 8.2% 6.0% 2.1%
   (5)-0   12.8%   15.2% 16.7% 19.6% 14.0%   (5)-0   13.7%   16.5% 17.9% 19.1% 17.0%   (5)-0   14.0%   18.1% 21.6% 21.7% 13.4%
   0-5   20.5%   24.8% 26.6% 31.6% 55.0%   0-5   20.4%   24.4% 28.8% 36.2% 44.3%   0-5   20.3%   24.3% 27.6% 36.8% 59.2%
   5-10   16.2%   16.9% 17.9% 22.3% 17.0%   5-10   17.3%   18.9% 18.7% 20.3% 33.0%   5-10   17.2%   17.5% 18.6% 22.3% 19.7%
   10-15   10.9%   11.1% 11.8% 8.9% 5.0%   10-15   10.4%   9.8% 8.3% 11.8% 1.9%   10-15   10.8%   9.1% 8.8% 6.6% 5.6%
   15-20   7.0%   6.5% 5.9% 5.3% 3.0%   15-20   6.3%   5.7% 6.1% 3.3% 1.9%   15-20   5.5%   5.4% 4.5% 2.6% 0.0%
   20-25   4.2%   3.4% 2.9% 1.6% 1.0%   20-25   4.0%   3.2% 3.7% 0.4% 0.0%   20-25   3.9%   3.3% 1.7% 0.9% 0.0%
   25-30   2.8%   2.4% 1.5% 0.4% 0.0%   25-30   2.2%   1.6% 1.7% 0.4% 0.0%   25-30   2.3%   1.9% 1.7% 0.1% 0.0%
   30-35   1.5%   1.3% 0.9% 0.1% 0.0%   30-35   1.4%   1.7% 0.7% 0.0% 0.0%   30-35   1.5%   0.8% 0.4% 0.3% 0.0%
   35-40   1.4%   0.9% 0.4% 0.3% 0.0%   35-40   1.1%   1.1% 0.3% 0.1% 0.0%   35-40   1.0%   0.8% 0.3% 0.2% 0.0%
   40-45   0.9%   0.4% 0.5% 0.0% 0.0%   40-45   0.8%   0.8% 0.2% 0.0% 0.0%   40-45   0.7%   0.2% 0.2% 0.0% 0.0%
   >45   3.4%   0.9% 0.4% 0.0% 0.0%   >45   3.6%   1.0% 0.4% 0.0% 0.0%   >45   3.4%   0.8% 0.2% 0.0% 0.0%
   Mean   6.3%   4.7% 4.1% 3.4% 3.1%   Mean   6.1%   4.9% 4.1% 3.3% 3.6%   Mean   5.5%   3.5% 3.0% 2.8% 3.1%
   Median   4.5%   3.8% 3.4% 3.3% 2.9%   Median   4.3%   3.6% 3.4% 3.0% 3.8%   Median   4.1%   2.9% 2.7% 2.9% 2.6%
   StDev   20.7%   13.1% 11.7% 9.4% 5.8%   StDev   21.5%   13.3% 10.7% 6.8% 4.3%   StDev   21.5%   12.7% 10.1% 7.3% 3.8%
  >$13,000 Mn   Base Rates   >$50,000 Mn   Base Rates   Full Universe   Base Rates
   CAGR (%)   1-Yr   3-Yr   5-Yr   10-Yr 20-Yr   CAGR (%)   1-Yr   3-Yr   5-Yr   10-Yr   20-Yr   CAGR (%)   1-Yr   3-Yr   5-Yr   10-Yr   20-Yr
   <(25)   3.8%   2.2% 1.4% 0.2% 0.0%   <(25)   4.4%   3.1% 3.6% 0.5%   0.0%   <(25)   4.0%   1.7% 1.1% 0.5%   0.1%
   (25)-(20)   1.3%   0.9% 1.2% 0.2% 0.0%   (25)-(20)   1.1%   0.9% 0.9% 0.5%   0.0%   (25)-(20)   1.6%   1.0% 0.7% 0.1%   0.1%
   (20)-(15)   2.2%   1.7% 1.5% 1.0% 0.0%   (20)-(15)   2.0%   1.6% 1.1% 0.9%   0.0%   (20)-(15)   2.6%   1.8% 1.4% 0.7%   0.1%
   (15)-(10)   3.6%   3.3% 2.8% 2.6% 0.0%   (15)-(10)   4.1%   3.6% 2.3% 5.7%   0.0%   (15)-(10)   3.9%   3.7% 2.9% 1.4%   0.4%
   (10)-(5)   8.6%   8.1% 7.5% 6.6% 4.6%   (10)-(5)   9.9%   9.5% 7.7% 4.7%   12.5%   (10)-(5)   7.0%   7.7% 7.0% 5.4%   1.8%
   (5)-0   17.1%   20.5% 20.7% 21.3% 26.9%   (5)-0   16.5%   20.9% 22.0% 23.1%   25.0%   (5)-0   12.7%   14.7% 16.5% 16.8%   11.5%
   0-5   22.3%   26.6% 31.5% 33.9% 36.9%   0-5   23.3%   28.2% 33.6% 34.9%   43.8%   0-5   17.6%   21.6% 24.6% 30.8%   43.0%
   5-10   17.2%   18.8% 18.2% 22.3% 26.9%   5-10   18.0%   19.5% 17.9% 25.9%   18.8%   5-10   15.4%   17.2% 18.7% 23.3%   25.9%
   10-15   8.7%   7.4% 7.9% 8.4% 4.6%   10-15   7.7%   6.6% 7.7% 3.3%   0.0%   10-15   10.6%   11.2% 11.7% 11.7%   11.8%
   15-20   5.1%   3.9% 3.5% 2.6% 0.0%   15-20   4.5%   2.9% 1.8% 0.5%   0.0%   15-20   6.9%   7.0% 6.9% 5.5%   3.9%
   20-25   3.3%   2.5% 2.1% 0.6% 0.0%   20-25   3.5%   1.6% 0.9% 0.0%   0.0%   20-25   4.7%   4.4% 3.5% 2.0%   0.6%
   25-30   2.0%   1.4% 0.6% 0.2% 0.0%   25-30   1.7%   0.5% 0.5% 0.0%   0.0%   25-30   3.2%   2.6% 2.1% 0.7%   0.6%
   30-35   1.1%   0.9% 0.7% 0.1% 0.0%   30-35   0.8%   0.2% 0.0% 0.0%   0.0%   30-35   2.1%   1.6% 1.0% 0.4%   0.1%
   35-40   0.8%   0.6% 0.2% 0.0% 0.0%   35-40   0.6%   0.4% 0.0% 0.0%   0.0%   35-40   1.6%   1.2% 0.6% 0.2%   0.2%
   40-45   0.6%   0.4% 0.1% 0.0% 0.0%   40-45   0.2%   0.2% 0.0% 0.0%   0.0%   40-45   1.2%   0.8% 0.4% 0.2%   0.0%
   >45   2.4%   0.7% 0.2% 0.0% 0.0%   >45   2.0%   0.2% 0.0% 0.0%   0.0%   >45   4.9%   1.9% 0.9% 0.3%   0.0%
   Mean   4.1%   2.8% 2.5% 2.6% 2.5%   Mean   2.4%   1.0% 1.0% 1.2%   1.2%   Mean   8.8%   6.2% 5.3% 4.6%   4.9%
   Median   3.0%   2.3% 2.2% 2.7% 2.6%   Median   2.6%   1.8% 1.7% 2.0%   0.6%   Median   5.2%   4.5% 4.2% 4.1%   4.2%
   StDev   18.6%   12.1% 9.8% 7.0% 4.7%   StDev   18.6%   11.6% 9.4% 6.5%   4.4%   StDev   50.3%   16.4% 13.1% 9.6%   6.7%

资料来源:FactSet。

Source: FactSet.

这批数据的价值在于细节,但整体上也有几点值得记住的观察。第一,随着公司规模上升,增长率的均值与中位数都会下降,增长率的标准差同样如此。这一点在实证上已经得到充分确认。16 图表 5 展示了三年年化增长率上的这一规律。教训是:对大公司的销售增长,要把预期放低一些。

While the value of these data is in the details, there are some useful observations about the whole that are worth keeping in mind. The first is that the mean and median growth rates decline as firm size increases, as does the standard deviation of the growth rates. This point has been well established empirically.16 Exhibit 5 shows this pattern for annualized growth rates over three years. The lesson is to temper expectations about sales growth for large companies.

图表 5:增长率与标准差随规模上升而下降

Exhibit 5: Growth Rates and Standard Deviations Decline with Size

   Mean   Median   Standard Deviation
35%
30%
25%
20%
15%
10%
  5%
  0%
   1   2   3   4   5   6   7   8   9   10   Mega   Universe
   Mean   Median   Standard Deviation
35%
30%
25%
20%
15%
10%
  5%
  0%
   1   2   3   4   5   6   7   8   9   10   Mega   Universe

十分位(按销售额从小到大排列)

Decile (Smallest to Largest by Sales)

资料来源:FactSet。

Source: FactSet.

注:增长率为三年年化数据;超大型公司指基期销售额超过 500 亿美元的公司。

Note: Growth rates are annualized over three years; mega companies have sales in excess of $50 billion in the base year.

其次,销售增长与国内生产总值(GDP)的走势相当接近(见图表 6)。GDP 增长与同年销售增长中位数之间的相关性很强,相关系数为 0.80。在这 21 年里,经通胀调整后的美国 GDP 年均增长 2.5%,标准差为 1.8%。

Next, sales growth follows gross domestic product (GDP) reasonably closely (see Exhibit 6). The correlation between GDP growth and the median sales growth in the same year is strong, with a coefficient of 0.80. Over the 21-year period, U.S. GDP grew at 2.5 percent per year, adjusted for inflation, with a standard deviation of 1.8 percent.

企业销售增长高于整体经济,原因有几个,包括并购、国际业务扩张以及汇率波动。17

Corporate sales growth was higher than that of the broader economy for a few reasons, including mergers and acquisitions, international growth, and currency swings.17

图表 6:销售增长率中位数与 GDP 增长相关

Exhibit 6: Median Sales Growth Rate Is Correlated with GDP Growth

原件此处是表格,PDF 抽取时列结构已丢失,下面只剩按列读出的数字,行列对应关系无法还原。核对数据请打开来源正文。

10%
   Sales Growth
  8%
  6%
   GDP Growth
  4%
  2%
  0%
 -2%
 -4%
 -6%
 -8%
   1994 1996 1998 2000 2002 2004 2006 2008 2010 2012 2014
10%
   Sales Growth
  8%
  6%
   GDP Growth
  4%
  2%
  0%
 -2%
 -4%
 -6%
 -8%
   1994 1996 1998 2000 2002 2004 2006 2008 2010 2012 2014

资料来源:FactSet 与美国经济分析局。

Source: FactSet and Bureau of Economic Analysis.

最后,尽管我们天然倾向于预期增长,样本中仍有 31% 的公司在经通胀调整后出现了三年销售负增长,30% 的公司在五年里销售萎缩。销售下滑如果出于正当理由,未必是坏事;但除非公司有明确的资产剥离战略,很少有分析师或企业领导人会预测销售萎缩。18

Finally, notwithstanding our natural tendency to anticipate growth, 31 percent of the companies in the sample had negative sales growth rates for 3 years, after an adjustment for inflation, and 30 percent shrunk for 5 years. Whereas a decline in sales need not be bad if it occurs for the right reasons, few analysts or corporate leaders project shrinking sales unless there is a clear strategy of divestiture.18

用基础比率为增长建模

Using Base Rates to Model Growth

我们已经确认,做预测有两条路。你可以自下而上做研究,这是最自然的方法;也可以求助于基础比率。决策研究显示,自下而上的方法容易受偏差影响,而纳入基础比率通常能提高预测的准确度。不过,我们既不想过度依赖自己的分析,也不想过度依赖基础比率,而是要把两者聪明地结合起来。

We have established that there are two ways of making a forecast. You can do bottom-up research, which is the most natural method, or you can turn to a base rate. The research in decision making shows that the bottom-up approach is subject to biases and that incorporating the base rate generally improves the accuracy of the forecast. Yet we don’t want to lean too much on either our own analysis or the base rate. We want to combine the two intelligently.

有一套技术可以把两种方法结合起来,我们将把它应用到销售增长数据上。19 相关性是这套方法的关键。相关性衡量的是两个分布中变量之间线性关系的强弱。

There is a technique to combine the two approaches, which we will apply to our sales growth data.19 Correlation is the key to the method. Correlation measures the degree of linear relationship between variables in a pair of distributions.

相关系数的取值介于 -1.0(一个变量的上升与另一个变量的下降完全对应)与 1.0(两个变量同向变动)之间。相关性为零意味着随机。我们考察的是单一变量,即销售增长随时间的表现,而所有相关系数都为正。

The value of a correlation can fall between -1.0 (the rise in one variable perfectly correlates with the fall of the other) and 1.0 (both variables move in tandem). A zero correlation indicates randomness. We will examine a single variable, sales growth, measured over time and all of the correlations are positive.

如果两个分布之间的相关性很高,那么此前发生的事就能很好地提示接下来会发生什么。举例来说,日常消费品行业公司的投资现金流回报率(CFROI®)在相邻两年之间的相关系数约为 0.90。20 这意味着,只要知道雀巢去年的 CFROI,你就能相当准确地预测它今年的数字。自下而上的功课在这里高度有用。

If the correlation between two distributions is high, then what happened before gives you a really good sense of what will follow. For example, the correlation for cash flow return on investment (CFROI®) for companies in the consumer staples sector is about 0.90 from one year to the next.20 That means if you know Nestlé’s CFROI from last year, you can forecast it this year with a great deal of accuracy. The bottom-up work is highly relevant.

如果相关性很低,此前发生的事就完全提示不了接下来会发生什么。以标普 500 指数的年度股东总回报(TSR)为例。21 从 1928 年到 2014 年,逐年之间的相关性基本为零。告诉你去年的回报率,对预测今年的回报毫无帮助。此时最好的预测就是参照类别的平均值。

If the correlation is low, what happened before provides no inkling of what will happen next. Take the annual total shareholder returns for the S&P 500 as a case.21 The correlation from year to year, from 1928 through 2014, is essentially zero. Telling you last year’s return provides no help in forecasting the return for this year. Your best forecast is the average of the reference class.

基本思路是:相关性决定了你该给自下而上的分析和基础比率各分配多少权重。对雀巢而言,一个合理的预测是九分取自去年的 CFROI,一分取自去年该行业的平均 CFROI,也就是基础比率。而对标普 500 的预测,你应该几乎不给去年的表现分配权重,主要依靠 1928 年以来的平均回报,也就是基础比率。

The basic idea is that the correlation determines how you should weight the bottom-up analysis and the base rate. For Nestlé, a sensible forecast is nine parts last year’s CFROI and one part last year’s average sector CFROI, the base rate. For your S&P 500 forecast, you should place minimal weight on what happened last year and rely largely on the average return since 1928, the base rate.

研究销售增长的基础比率合乎逻辑,有两个原因。第一,对多数公司而言,销售增长是最重要的价值驱动因素。第二,销售增长逐年之间的相关性,高于利润表上被谈论得最多的项目,也就是盈利增长。22 销售增长既重要,又比利润增长更可预测。

Studying base rates for sales growth is logical for two reasons. First, sales growth is the most important driver of value for most companies. Second, sales growth has a higher correlation from year to year than does earnings growth, which is the most commonly discussed item on the income statement.22 Sales growth is important and more predictable than profit growth.

图表 7 显示,逐年销售增长率的相关系数为 0.27。我们以 1994 年的标普 1500 指数成分股为起点,使用 1994 至 2014 年的数据。23 具体来说,我们把 1994 年的增长率与 1995 年的相关联,1995 年与 1996 年相关联,以此类推。结果表明,即便只考察销售额超过 200 亿美元的公司,这一相关性也变化不大。

Exhibit 7 shows that the correlation coefficient is 0.27 for the year-to-year sales growth rate. We start with the constituents of the S&P 1500 Index as of 1994, and use the figures from 1994 through 2014.23 Specifically, we correlate the growth rates of 1994 with those of 1995, 1995 with 1996, et cetera. It turns out that the correlation doesn’t change much if we consider only companies with sales in excess of $20 billion.

图表 7:一年期销售增长率的相关性 r = 0.27 75%

Exhibit 7: Correlation of One-Year Sales Growth Rates r = 0.27 75%

次年销售增长 0% -75% 0% 75%

Sales Growth Following Year 0% -75% 0% 75%

-75% 上一年销售增长 资料来源:FactSet。

-75% Sales Growth Prior Year Source: FactSet.

不出所料,随着考察的时间跨度拉长,相关性趋于下降。图表 8 给出了全部公司总体在 1 年、3 年、5 年和 10 年期的相关系数。教训是:在做三年及以上的预测时,参照类别的基础比率,也就是中位数增长率,应当占据大部分权重。事实上,你不妨先从基础比率出发,再去寻找偏离它的理由。

The correlations tend to decline as we consider longer time periods, which comes as no surprise. Exhibit 8 shows the correlations for 1-, 3-, 5-, and 10-year horizons for the full population of companies. The lesson is that the base rate for the reference classes, the median growth rate, should receive the majority of the weight for forecasts of three years or longer. In fact, you might start with the base rate and seek reasons to move away from it.

图表 8:1 年、3 年、5 年与 10 年期销售增长率的相关性 0.30 0.27

Exhibit 8: Correlation of Sales Growth Rates for 1-, 3-, 5- and 10-Year Horizons 0.30 0.27

相关系数(r) 0.14 0.13 0.12

Correlation (r) 0.14 0.13 0.12

0.00 1 年 3 年 5 年 10 年 期间 资料来源:FactSet。

0.00 1-Year 3-Year 5-Year 10-Year Period Source: FactSet.

这种为向均值回归建模的方法,并不是说没有公司会快速增长,也不是说没有公司会萎缩。我们清楚,总会有公司填满分布的两端尾部。它真正想说的是:对一大批公司而言,最好的预测是接近中位数的数字;而那些预期销售增长远高于中位数的公司,大概率会失望。

This approach to modelling regression toward the mean doesn’t say that some companies won’t grow rapidly and others won’t shrink. We know that companies will fill the tails of the distribution. What it does say is that the best forecast for a large sample of companies is something close to the median, and that companies that anticipate sales growth well in excess of the median are likely to be disappointed.

案例研究

Case Studies

我们已经把埃隆·马斯克为特斯拉未来十年设想的情景与基础比率做了对照。现在我们来看几个成功与失败的案例。

We have already compared Elon Musk’s scenario for Tesla’s next decade to a base rate. We now turn to some case studies of successes and failures.

第一个案例是苹果,结果令人惊叹。事实上,这家公司在两个时代都取得了非凡的成绩(见图表 9)。1981 至 1990 年间,公司销售额以 36% 的复合年增长率增长。

The first case is Apple, and the results are astounding. In fact, the company has had extraordinary results in two eras (see Exhibit 9). From 1981 through 1990, the company’s sales grew at a CAGR of 36 percent.

这个成绩固然亮眼,但起点是相对较低的 4 亿美元销售基数。即便如此,同等规模的公司中,能达到这一增速的也不到千分之五。

While impressive, this was off a relatively low starting sales base of $400 million. Still it was a rate of growth achieved by less than one-half of one percent of companies of a similar size.

图表 9:苹果的非凡增长,当年(1981-1990)与如今(2003-2013)

Exhibit 9: Apple’s Extraordinary Growth, Then (1981-1990) and Now (2003-2013)

10-Year Period   Real CAGR   Yr (0) Sales   Base Rate
   1981-1990   36.4%   418   4 out of 833   0.48%
   2003-2012   36.2%   7,463   2 out of 1251   0.16%
   2004-2013   35.6%   8,396   2 out of 1251   0.16%
10-Year Period   Real CAGR   Yr (0) Sales   Base Rate
   1981-1990   36.4%   418   4 out of 833   0.48%
   2003-2012   36.2%   7,463   2 out of 1251   0.16%
   2004-2013   35.6%   8,396   2 out of 1251   0.16%

资料来源:FactSet。

Source: FactSet.

注:数据以 2014 年美元计。

Note: Figures in 2014 U.S. Dollars.

苹果在过去十来年的增长同样了不起。在与苹果规模相当(60 亿至 130 亿美元)的 1,251 家公司中,只有 2 例做到了十年间销售额以 35% 至 40% 的复合年增长率增长。两例都是苹果。而这一切并未依靠任何重大收购,使这一成就更加不同凡响。

Apple’s growth in the last dozen years has also been truly amazing. Out of the 1,251 companies in Apple’s size cohort ($6-13 billion), there were only 2 instances of sales growth of 35-40 percent compounded annually over 10 years. Both were Apple. That this was without any major acquisitions makes the feat even more remarkable.

把 21 世纪初的苹果与另一家实现了快速增长的公司微软做比较,会很有意思。我们按经通胀调整后的销售额为两家公司配对,据此选定苹果的 2003 财年与微软的 1995 财年作为基期,再考察其后十年的销售增长(见图表 10)。请注意纵轴采用对数刻度,也就是说刻度之间的间距代表相同的百分比变化(1 到 10 与 10 到 100 是一样的)。苹果的销售增速大致是微软的两倍。

It is interesting to compare Apple in the early 2000s to Microsoft, another company that realized rapid growth. We matched the two companies based on sales, adjusted for inflation, which suggest fiscal 2003 as the base year for Apple and fiscal 1995 for Microsoft. We then examine the sales growth for the subsequent decade (see Exhibit 10). Note that the vertical axis is on a logarithmic scale, which means that the difference between the tick marks reflects the same percentage change (1 to 10 is the same as 10 to 100). Apple grew sales at a rate roughly double that of Microsoft.

图表 10:苹果(2003-2013 财年)与微软(1995-2005 财年)的销售额与毛利率

Exhibit 10: Sales and Gross Margins for Apple (F2003-13) and Microsoft (F1995-2005)

微软销售额 苹果销售额 微软毛利率 苹果毛利率 10,000 200

Microsoft Sales Apple Sales Microsoft Gross Margin Apple Gross Margin 10,000 200

180

180

实际销售额指数(第 0 年 = 100)

Real Sales Indexed (Year 0 = 100)

160

160

毛利率(百分比)

Gross Profit Margin (Percent)

原件此处是表格,PDF 抽取时列结构已丢失,下面只剩按列读出的数字,行列对应关系无法还原。核对数据请打开来源正文。

1,000
   140
   120
 100   100
   80
   60
  10
   40
   20
   1   0
   0   1   2   3   4   5   6   7   8   9   10
   Years
1,000
   140
   120
 100   100
   80
   60
  10
   40
   20
   1   0
   0   1   2   3   4   5   6   7   8   9   10
   Years

资料来源:FactSet。

Source: FactSet.

注:数据以 2014 年美元计。

Note: Figures in 2014 U.S. Dollars.

图表 10 还给出了两家公司各年度的毛利率。以软件为主业的微软,平均毛利率超过 85%;以硬件为主业的苹果,平均毛利率为 35%。

Exhibit 10 also shows the annual gross margin for each company. Microsoft, primarily a software company, had an average gross margin of more than 85 percent while Apple, primarily a hardware company, averaged 35 percent.

苹果如今 2000 亿美元的销售规模,会不会成为公司增长的天花板?公司首席执行官蒂姆·库克并不这么看。以下是他近期的说法(着重处为作者所加):24

Will the level of sales of Apple, now at $200 billion, place a limit on the company’s growth? Tim Cook, the company’s CEO, doesn’t think so. Here’s what he said recently (emphasis added):24

你知道,我们很幸运有了不错的一年,但对这个问题最重要的回答也许首先是:我们不相信什么大数定律。我想这算是一种老掉牙的教条,是某个人凭空炮制出来的。史蒂夫(乔布斯)这些年为我们做了很多事,而他反复灌输给我们的一点是:给自己的思维设限从来不是好事。所以我们其实并不盯着数字看,我们盯的是那些能创造出数字的东西,对吧?

Y’know, we’re fortunate to have a good year, but maybe the most important answer to that first would be that we don’t believe in such laws as laws of large numbers. This is sort of, uh, old dogma, I think, that was cooked up by somebody and Steve [Jobs] did a lot of things for us for many years, but one of the things he ingrained in us [is] that putting limits on your thinking [is] never good. And so, we’re actually not focused on numbers, we're focused on the things that produce the numbers, right?

苹果说明,基础比率并非宿命。正如丹·洛瓦洛与丹尼尔·卡尼曼所写:“外部视角(也就是基础比率)建立在历史先例之上,确实可能预测不了极端结果,也就是那些落在所有历史先例之外的结果。但对绝大多数项目而言,外部视角会给出更好的结果。”25

Apple shows that base rates are not destiny. As Dan Lovallo and Daniel Kahneman write, “It’s true that the outside view [the base rate], being based on historical precedent, may fail to predict extreme outcomes— those that lie outside all historical precedents. But for most projects, the outside view will produce superior results.”25

亚马逊是另一家长期保持惊人营收增长的公司。一个有趣的对比是亚马逊与沃尔玛。两家公司在各自首次公开发行(IPO)时,经通胀调整后的销售规模相近。亚马逊 1997 年上市,沃尔玛 1970 年上市。图表 11 展示了两家公司上市后十年的销售增长。二者的销售增速都极为迅猛:亚马逊约为每年复合增长 55%,沃尔玛约为 34%。

Amazon.com is another company that has sustained remarkable top line growth. One interesting comparison is between Amazon and Wal-Mart Stores, Inc. The companies had a similar level of sales, adjusted for inflation, at the time of their respective initial public offerings (IPOs). Amazon’s IPO was in 1997 and Wal-Mart’s in 1970. Exhibit 11 shows the sales growth of both companies for the ten years following their IPOs. Both realized torrid sales growth: Amazon about 55 percent compounded annually and Wal-Mart about 34 percent.

图表 11:沃尔玛与亚马逊上市后十年的销售额与毛利率 沃尔玛销售额 亚马逊销售额 沃尔玛毛利率 亚马逊毛利率 10,000 60

Exhibit 11: Sales and Gross Margins for Wal-Mart and Amazon.com, Ten Years Post-IPO Wal-Mart Sales Amazon Sales Wal-Mart Gross Margin Amazon Gross Margin 10,000 60

50

50

实际销售额指数(第 0 年 = 100)

Real Sales Indexed (Year 0 = 100)

毛利率(百分比)

Gross Profit Margin (Percent)

原件此处是表格,PDF 抽取时列结构已丢失,下面只剩按列读出的数字,行列对应关系无法还原。核对数据请打开来源正文。

1,000
   40
 100   30
   20
  10
   10
   1   0
   0   1   2   3   4   5   6   7   8   9   10
1,000
   40
 100   30
   20
  10
   10
   1   0
   0   1   2   3   4   5   6   7   8   9   10

首次公开发行后的年数 资料来源:公司申报文件与 FactSet。

Years Following Initial Public Offering Source: Company filings and FactSet.

图表 11 还给出了两家公司的毛利率。沃尔玛的毛利率处在 25% 上下,而亚马逊除了互联网泡沫顶峰期的大手笔投入之外,一直处在 20% 出头

Exhibit 11 also shows the gross margins for each company. Wal-Mart’s gross margin was in the mid-20 percent range, while Amazon, save the heavy spending during the peak of the dot-com bubble, was in the low

的水平。2014 年,沃尔玛的毛利率约为 25%,亚马逊则超过 29%。

20s. In 2014, Wal-Mart’s gross margin was about 25 percent and Amazon’s was in excess of 29 percent.

伯克希尔·哈撒韦董事长兼首席执行官沃伦·巴菲特,对那些预测高速增长的公司发出过警告。以下摘自他 2000 年致股东的信。虽然当时正值互联网泡沫,这段话仍值得完整引用(着重处为作者所加):26

Warren Buffett, the chairman and CEO of Berkshire Hathaway, sounds a cautionary note about companies that predict rapid growth. Here’s an excerpt from his letter to shareholders in 2000. While this was during the dot-com bubble, the passage bears quoting in full (emphasis added):26

趁我还站在这个讲台上,再补一个想法:查理(芒格)和我都认为,首席执行官预测自家公司的增长率,既有误导性又有危险。当然,他们常常是被分析师和自家投资者关系部门撺掇着这么做的。但他们应该顶住,因为这类预测太经常招来麻烦。

One further thought while I’m on my soapbox: Charlie [Munger] and I think it is both deceptive and dangerous for CEOs to predict growth rates for their companies. They are, of course, frequently egged on to do so by both analysts and their own investor relations departments. They should resist, however, because too often these predictions lead to trouble.

首席执行官为自己设定内部目标没有问题;在我们看来,只要伴随合理的免责说明,公开表达一些对未来的期望也无可厚非。但一家大公司若预测其每股收益将长期以比如说每年 15% 的速度增长,那就是自找麻烦。

It’s fine for a CEO to have his own internal goals and, in our view, it’s even appropriate for the CEO to publicly express some hopes about the future, if these expectations are accompanied by sensible caveats. But for a major corporation to predict that its per-share earnings will grow over the long term at, say, 15% annually is to court trouble.

之所以如此,是因为只有极小比例的大企业才能维持这种量级的增长率。这里有个检验方法:翻出 1970 年或 1980 年盈利最高的 200 家公司,统计一下其中有多少家自那时起把每股收益的年增速做到了 15%。你会发现屈指可数。我愿意拿一大笔钱跟你打赌:2000 年最赚钱的 200 家公司里,未来 20 年能实现每股收益年增长 15% 的,不会超过 10 家。

That’s true because a growth rate of that magnitude can only be maintained by a very small percentage of large businesses. Here’s a test: Examine the record of, say, the 200 highest earning companies from 1970 or 1980 and tabulate how many have increased per-share earnings by 15% annually since those dates. You will find that only a handful have. I would wager you a very significant sum that fewer than 10 of the 200 most profitable companies in 2000 will attain 15% annual growth in earnings-per-share over the next 20 years.

好高骛远的预测带来的问题,不只是散播了没有根据的乐观。更麻烦的是,它会腐蚀 CEO 的行为。这些年来,查理和我见过许多这样的例子:CEO 为了兑现自己先前宣布的盈利目标,采取了并不经济的经营动作。更糟的是,当经营上的腾挪手段用尽之后,他们有时会玩出五花八门的会计花招,好把数字“做出来”。这类会计把戏往往越滚越大:一家公司一旦把盈利从一个期间挪到另一个期间,此后再出现经营缺口,就必须动用更多、而且更“英勇”的会计操作。这些操作能把粉饰变成欺诈。(有人说过,用笔尖偷走的钱,比用枪口抢走的还多。)

The problem arising from lofty predictions is not just that they spread unwarranted optimism. Even more troublesome is the fact that they corrode CEO behavior. Over the years, Charlie and I have observed many instances in which CEOs engaged in uneconomic operating maneuvers so that they could meet earnings targets they had announced. Worse still, after exhausting all that operating acrobatics would do, they sometimes played a wide variety of accounting games to “make the numbers.” These accounting shenanigans have a way of snowballing: Once a company moves earnings from one period to another, operating shortfalls that occur thereafter require it to engage in further accounting maneuvers that must be even more “heroic.” These can turn fudging into fraud. (More money, it has been noted, has been stolen with the point of a pen than at the point of a gun.)

对于那些用花哨预测来取悦投资者的 CEO 所掌管的公司,查理和我通常心存戒备。这些管理者中会有少数事后证明确有先见之明,另一些则会被证明是天生的乐观派,甚至是江湖骗子。

Charlie and I tend to be leery of companies run by CEOs who woo investors with fancy predictions. A few of these managers will prove prophetic — but others will turn out to be congenital optimists, or even charlatans.

遗憾的是,投资者很难事先看出自己面对的是哪一类。

Unfortunately, it’s not easy for investors to know in advance which species they are dealing with.

当然,并非所有例子都是成功故事。伊士曼柯达公司和诺基亚公司就是近年来因技术变迁而陷入苦战的两家公司。柯达在胶卷业务上曾拥有主导地位,利润也极为丰厚,但随着数码摄影兴起,这一特许经营权承受了巨大压力。公司于 2012 年初申请破产,此后继续重组业务。在截至 2014 年的十年里,柯达销售额以接近 19% 的复合年率下滑。降幅中有一部分来自资产剥离。

Naturally, not all of the examples are success stories. The Eastman Kodak Company and Nokia Corporation are two companies that have struggled in recent years as the result of technological change. Kodak had a dominant, and highly profitable, franchise in photo film that came under severe pressure as digital photography took off. The company filed for bankruptcy in early 2012 and continued to restructure the business. In the decade ended 2014, Kodak’s sales declined at a compounded annual rate of close to 19 percent. Part of this decline is attributable to divestitures.

诺基亚曾是智能手机以及传统手机市场的领导者,它在高端的领先地位被苹果和三星掀翻,低端则被亚洲厂商蚕食。截至 2014 年的 10 年间,其销售额以每年 9% 的复合速度萎缩。诺基亚 2008 年的销售额是 2014 年的四倍多,其中资产剥离同样起了作用。

Nokia, once a leader in the smartphone as well as the traditional mobile phone market, saw its lead at the top end toppled by Apple and Samsung and at the low end by Asian manufacturers. Sales for the 10 years ended 2014 shrank 9 percent compounded annually. Nokia’s sales in 2008 were more than four times those of 2014, with divestitures again playing a role.

图表 12 展示了柯达与诺基亚 2004 年至 2014 年的销售额和毛利率。这些案例说明,曾经强大而自负的公司也会失足,并最终萎缩。销售增长率的分布虽然右偏,但必须认识到,同样有大量企业在收缩。

Exhibit 12 shows the sales and gross profit margin for Kodak and Nokia from 2004 through 2014. These cases show how once strong and proud companies can stumble, and ultimately shrink. While the distribution of sales growth rates is skewed to the right, it’s important to recognize that plenty of businesses also shrink.

图表 12:伊士曼柯达与诺基亚的销售额与毛利率,2004-14 年 伊士曼柯达销售额 诺基亚销售额 伊士曼柯达毛利率 诺基亚毛利率 1,000 120

Exhibit 12: Sales and Gross Margins for Eastman Kodak and Nokia, 2004-14 Eastman Kodak Sales Nokia Sales Eastman Kodak Gross Margin Nokia Gross Margin 1,000 120

100

100

实际销售额指数(第 0 年 = 100)

Real Sales Indexed (Year 0 = 100)

毛利率(百分比)

Gross Profit Margin (Percent)

原件此处是表格,PDF 抽取时列结构已丢失,下面只剩按列读出的数字,行列对应关系无法还原。核对数据请打开来源正文。

100   80
   60
 10   40
   20
  1   0
   0   1   2   3   4   5   6   7   8   9   10
   Years
100   80
   60
 10   40
   20
  1   0
   0   1   2   3   4   5   6   7   8   9   10
   Years

资料来源:FactSet。

Source: FactSet.

当前预期

Current Expectations

图表 1 展示了美国一千多家上市公司未来三年销售增长的当前预期。预期增长率的中位数为 2.7%,与 2-3% 的 GDP 增速一致。

Exhibit 1 showed the current expectations for sales growth over three years for more than a thousand public companies in the U.S. The median expected growth rate is 2.7 percent, which is consistent with GDP growth of 2-3 percent.

图表 13 展示了分析师对十家销售额超过 500 亿美元的公司所预期的三年销售增长率,数据已按通胀调整。我们把这些预期增长率叠加在超大型公司这一参照类别的历史销售增长率分布之上。

Exhibit 13 shows the three-year sales growth rates, adjusted for inflation, which analysts expect for ten companies with sales in excess of $50 billion. We superimposed the expected growth rates on the distribution of historical sales growth rates for the reference class of mega companies.

图表 13:十家超大型公司的三年预期销售增长率 30 富国银行 沃尔玛 摩根大通 25 强生 微软 埃克森

Exhibit 13: Three-Year Expected Sales Growth Rates for Ten Mega Companies 30 Wells Fargo Wal-Mart JP Morgan 25 J&J Microsoft Exxon

频率(百分比)

Frequency (Percent)

20 P&G

20 P&G

15 GE

15 GE

10 苹果

10 Apple

原件此处是表格,PDF 抽取时列结构已丢失,下面只剩按列读出的数字,行列对应关系无法还原。核对数据请打开来源正文。

   Google
5
0
   5-10
   (10)-(5)   40-45
   (5)-0   0-5
   10-15   15-20   20-25   25-30   30-35   35-40
   (20)-(15)
   <(25)   >45
   (25)-(20)   (15)-(10)
   Google
5
0
   5-10
   (10)-(5)   40-45
   (5)-0   0-5
   10-15   15-20   20-25   25-30   30-35   35-40
   (20)-(15)
   <(25)   >45
   (25)-(20)   (15)-(10)

销售额复合年增长率(百分比)

Sales CAGR (Percent)

资料来源:FactSet。

Source: FactSet.

注:I/B/E/S 一致预期数据截至 2015 年 5 月 4 日;增长率均为年化值;J&J = 强生,GE = 通用电气,Exxon = 埃克森美孚,P&G = 宝洁。

Note: I/B/E/S consensus estimates as of May 4, 2015; Growth rates are annualized; J&J = Johnson & Johnson, GE = General Electric, Exxon = ExxonMobil, and P&G = Procter & Gamble.

十家公司中有四家被分析师预期为销售负增长,这在很大程度上可由公司层面的动作或大宗商品价格来解释。这一小样本的增长率标准差为 5.7%。

Analysts expect negative sales growth for four of the ten, which corporate actions or commodity prices can largely explain. The standard deviation of growth rates for this small sample is 5.7 percent.

总结

Summary

主动投资要求你持有一个与股票市场不同的观点。这种异见之中隐含着一个预测,它与市场所暗示的结果相左。

Active investing requires having a point of view that is different than that of the stock market. Implicit in such a variant perception is a forecast of outcomes that is at odds with what the market implies.

研究显示,乐观与过度自信会悄悄渗入我们的预测,使其失真。当结果与我们自身利害相关时,尤其如此。研究同样显示,纳入基础比率能提高预测的质量。尽管这一方法很有用,它至今仍远未被充分利用。

Research shows that optimism and overconfidence can creep into our forecasts, thus distorting them. This is especially true when the outcomes have personal relevance. Research also shows that incorporating a base rate can improve the quality of our forecasts. Notwithstanding the utility of this method, it remains substantially underutilized.

在本文中,我们给出了一个规模庞大的美国公司样本在二十多年跨度上的销售增长率基础比率。我们从销售增长入手,因为它是最重要的价值驱动因素。随后我们提供一套方法,把我们自己的看法以及过去的结果与基础比率结合起来,从而磨利预测的质量。我们还分享了几个案例研究,说明一些异常值后来的遭遇。

In this piece we provide the base rates for sales growth rates for a large sample of U.S. companies over a span of more than two decades. We start with sales growth because it is the most important value driver. We then provide a method to integrate our views, as well as results from the past, with base rates to sharpen the quality of our forecasts. We also share a few case studies to show what happened to some outliers.

附录:标普 1500 各项基础比率按十分位的观测值(1994-2014)

Appendix: Observations for Each Base Rate by Decile for S&P 1500 (1994-2014)

原件此处是表格,PDF 抽取时列结构已丢失,下面只剩按列读出的数字,行列对应关系无法还原。核对数据请打开来源正文。

   $0-250 Mn   Observations   $250-450 Mn   Observations   $450-700 Mn   Observations
Sales CAGR (%)   1-Yr  3-Yr  5-Yr 10-Yr   20-Yr   Sales CAGR (%)   1-Yr  3-Yr  5-Yr 10-Yr   20-Yr   Sales CAGR (%)   1-Yr  3-Yr  5-Yr 10-Yr   20-Yr
   <(25)   158   78   61   22   1   <(25)   108   34   15   2   0   <(25)   111   31   8   2   0
   (25)-(20)   52   26   10   2   0   (25)-(20)   42   17   9   1   0   (25)-(20)   46   26   4   0   0
   (20)-(15)   63   35   20   15   0   (20)-(15)   77   41   17   2   0   (20)-(15)   79   47   37   2   0
   (15)-(10)   92   62   33   8   0   (15)-(10)   87   67   49   7   0   (15)-(10)   128   84   60   19   0
   (10)-(5)   145   124   70   16   2   (10)-(5)   162   118   89   33   0   (10)-(5)   185   178   107   66   0
   (5)-0   213   176   158   60   5   (5)-0   285   208   179   131   4   (5)-0   294   243   227   133   8
   0-5   266   249   221   146   22   0-5   354   362   315   184   30   0-5   411   395   344   251   38
   5-10   251   240   234   169   33   5-10   333   352   314   198   26   5-10   427   414   353   255   32
   10-15   225   215   183   128   31   10-15   306   309   266   137   20   10-15   319   299   285   157   26
   15-20   178   157   170   89   18   15-20   223   180   150   81   6   15-20   219   218   160   59   4
   20-25   123   143   84   62   3   20-25   165   153   92   37   1   20-25   156   147   79   20   0
   25-30   110   102   72   27   6   25-30   118   93   58   9   0   25-30   129   58   55   7   1
   30-35   90   63   49   18   1   30-35   69   49   26   2   0   30-35   89   39   14   6   0
   35-40   71   57   34   9   2   35-40   74   36   18   4   0   35-40   54   30   14   3   0
   40-45   61   39   21   12   0   40-45   62   34   16   4   0   40-45   43   21   7   1   0
   >45   312   158   87   25   0   >45   182   67   16   1   0   >45   161   48   15   1   0
   Total   2,410 1,924 1,507 808   124   Total   2,647 2,120 1,629 833   87   Total   2,851 2,278 1,769 982   109
 $700-1,000 Mn   Observations   $1,000-1,500 Mn   Observations   $1,500-2,250 Mn   Observations
Sales CAGR (%)   1-Yr  3-Yr  5-Yr 10-Yr   20-Yr   Sales CAGR (%)   1-Yr  3-Yr  5-Yr 10-Yr   20-Yr   Sales CAGR (%)   1-Yr  3-Yr  5-Yr 10-Yr   20-Yr
   <(25)   98   31   4   3   0   <(25)   108   29   17   8   0   <(25)   99   31   11   2   0
   (25)-(20)   46   32   18   0   0   (25)-(20)   53   19   9   1   0   (25)-(20)   57   24   12   4   0
   (20)-(15)   74   27   19   11   0   (20)-(15)   85   50   20   6   1   (20)-(15)   73   48   24   3   0
   (15)-(10)   120   92   48   14   2   (15)-(10)   125   89   53   7   0   (15)-(10)   124   94   58   10   1
   (10)-(5)   211   199   135   32   2   (10)-(5)   223   215   169   35   0   (10)-(5)   205   183   135   90   3
   (5)-0   368   317   285   128   7   (5)-0   377   391   362   204   8   (5)-0   387   372   352   170   13
   0-5   464   484   460   308   44   0-5   520   531   472   339   54   0-5   558   572   515   409   57
   5-10   442   373   322   221   38   42134   485   405   402   331   27   5-10   473   483   440   278   23
   10-15   284   283   242   154   11   15-Oct   353   332   282   139   9   10-15   369   307   237   120   16
   15-20   237   202   153   79   6   15-20   213   204   158   64   2   15-20   210   169   128   56   3
   20-25   144   108   75   24   1   20-25   163   107   68   13   0   20-25   139   87   65   14   1
   25-30   101   68   38   10   0   25-30   104   59   34   9   0   25-30   84   59   28   6   0
   30-35   72   48   15   8   0   30-35   62   38   19   2   0   30-35   57   25   12   3   0
   35-40   51   32   12   2   0   35-40   39   24   8   1   0   35-40   51   20   6   1   0
   40-45   32   8   6   0   0   40-45   32   18   8   0   0   40-45   29   13   7   1   0
   >45   125   30   17   0   0   >45   132   37   13   0   0   >45   119   37   8   0   0
   Total   2,869 2,334 1,849 994   111   Total   3,074 2,548 2,094 1,159   101   Total   3,034 2,524 2,038 1,167   117
   $0-250 Mn   Observations   $250-450 Mn   Observations   $450-700 Mn   Observations
Sales CAGR (%)   1-Yr  3-Yr  5-Yr 10-Yr   20-Yr   Sales CAGR (%)   1-Yr  3-Yr  5-Yr 10-Yr   20-Yr   Sales CAGR (%)   1-Yr  3-Yr  5-Yr 10-Yr   20-Yr
   <(25)   158   78   61   22   1   <(25)   108   34   15   2   0   <(25)   111   31   8   2   0
   (25)-(20)   52   26   10   2   0   (25)-(20)   42   17   9   1   0   (25)-(20)   46   26   4   0   0
   (20)-(15)   63   35   20   15   0   (20)-(15)   77   41   17   2   0   (20)-(15)   79   47   37   2   0
   (15)-(10)   92   62   33   8   0   (15)-(10)   87   67   49   7   0   (15)-(10)   128   84   60   19   0
   (10)-(5)   145   124   70   16   2   (10)-(5)   162   118   89   33   0   (10)-(5)   185   178   107   66   0
   (5)-0   213   176   158   60   5   (5)-0   285   208   179   131   4   (5)-0   294   243   227   133   8
   0-5   266   249   221   146   22   0-5   354   362   315   184   30   0-5   411   395   344   251   38
   5-10   251   240   234   169   33   5-10   333   352   314   198   26   5-10   427   414   353   255   32
   10-15   225   215   183   128   31   10-15   306   309   266   137   20   10-15   319   299   285   157   26
   15-20   178   157   170   89   18   15-20   223   180   150   81   6   15-20   219   218   160   59   4
   20-25   123   143   84   62   3   20-25   165   153   92   37   1   20-25   156   147   79   20   0
   25-30   110   102   72   27   6   25-30   118   93   58   9   0   25-30   129   58   55   7   1
   30-35   90   63   49   18   1   30-35   69   49   26   2   0   30-35   89   39   14   6   0
   35-40   71   57   34   9   2   35-40   74   36   18   4   0   35-40   54   30   14   3   0
   40-45   61   39   21   12   0   40-45   62   34   16   4   0   40-45   43   21   7   1   0
   >45   312   158   87   25   0   >45   182   67   16   1   0   >45   161   48   15   1   0
   Total   2,410 1,924 1,507 808   124   Total   2,647 2,120 1,629 833   87   Total   2,851 2,278 1,769 982   109
 $700-1,000 Mn   Observations   $1,000-1,500 Mn   Observations   $1,500-2,250 Mn   Observations
Sales CAGR (%)   1-Yr  3-Yr  5-Yr 10-Yr   20-Yr   Sales CAGR (%)   1-Yr  3-Yr  5-Yr 10-Yr   20-Yr   Sales CAGR (%)   1-Yr  3-Yr  5-Yr 10-Yr   20-Yr
   <(25)   98   31   4   3   0   <(25)   108   29   17   8   0   <(25)   99   31   11   2   0
   (25)-(20)   46   32   18   0   0   (25)-(20)   53   19   9   1   0   (25)-(20)   57   24   12   4   0
   (20)-(15)   74   27   19   11   0   (20)-(15)   85   50   20   6   1   (20)-(15)   73   48   24   3   0
   (15)-(10)   120   92   48   14   2   (15)-(10)   125   89   53   7   0   (15)-(10)   124   94   58   10   1
   (10)-(5)   211   199   135   32   2   (10)-(5)   223   215   169   35   0   (10)-(5)   205   183   135   90   3
   (5)-0   368   317   285   128   7   (5)-0   377   391   362   204   8   (5)-0   387   372   352   170   13
   0-5   464   484   460   308   44   0-5   520   531   472   339   54   0-5   558   572   515   409   57
   5-10   442   373   322   221   38   42134   485   405   402   331   27   5-10   473   483   440   278   23
   10-15   284   283   242   154   11   15-Oct   353   332   282   139   9   10-15   369   307   237   120   16
   15-20   237   202   153   79   6   15-20   213   204   158   64   2   15-20   210   169   128   56   3
   20-25   144   108   75   24   1   20-25   163   107   68   13   0   20-25   139   87   65   14   1
   25-30   101   68   38   10   0   25-30   104   59   34   9   0   25-30   84   59   28   6   0
   30-35   72   48   15   8   0   30-35   62   38   19   2   0   30-35   57   25   12   3   0
   35-40   51   32   12   2   0   35-40   39   24   8   1   0   35-40   51   20   6   1   0
   40-45   32   8   6   0   0   40-45   32   18   8   0   0   40-45   29   13   7   1   0
   >45   125   30   17   0   0   >45   132   37   13   0   0   >45   119   37   8   0   0
   Total   2,869 2,334 1,849 994   111   Total   3,074 2,548 2,094 1,159   101   Total   3,034 2,524 2,038 1,167   117

原件此处是表格,PDF 抽取时列结构已丢失,下面只剩按列读出的数字,行列对应关系无法还原。核对数据请打开来源正文。

$2,250-3,500 Mn   Observations   $3,500-6,000 Mn   Observations   $6,000-13,000 Mn   Observations
Sales CAGR (%)   1-Yr  3-Yr  5-Yr 10-Yr   20-Yr   Sales CAGR (%)   1-Yr  3-Yr  5-Yr 10-Yr   20-Yr   Sales CAGR (%)   1-Yr  3-Yr  5-Yr 10-Yr   20-Yr
   <(25)   112   38   12   8   0   <(25)   110   33   17   3   0   <(25)   124   40   27   3   0
   (25)-(20)   45   23   8   3   1   (25)-(20)   37   24   15   1   0   (25)-(20)   51   30   14   0   0
   (20)-(15)   83   49   39   4   0   (20)-(15)   64   36   27   7   0   (20)-(15)   78   44   23   12   0
   (15)-(10)   112   97   68   21   1   (15)-(10)   128   95   61   11   0   (15)-(10)   111   103   68   18   0
   (10)-(5)   190   183   168   73   3   (10)-(5)   216   186   135   68   2   (10)-(5)   228   230   173   75   3
   (5)-0   373   367   333   216   14   (5)-0   405   403   351   204   18   (5)-0   425   458   455   271   19
   0-5   597   600   532   349   55   0-5   602   596   565   387   47   0-5   618   615   582   460   84
   5-10   473   408   358   246   17   5-10   512   460   367   217   35   5-10   522   443   393   279   28
   10-15   317   267   235   98   5   10-15   307   238   162   126   2   10-15   327   231   185   82   8
   15-20   203   158   117   59   3   15-20   185   138   120   35   2   15-20   168   137   95   33   0
   20-25   123   83   58   18   1   20-25   119   78   73   4   0   20-25   117   83   35   11   0
   25-30   83   59   29   4   0   25-30   66   39   34   4   0   25-30   69   48   36   1   0
   30-35   45   31   17   1   0   30-35   42   41   14   0   0   30-35   47   20   9   4   0
   35-40   40   21   7   3   0   35-40   33   26   6   1   0   35-40   29   20   6   2   0
   40-45   25   10   9   0   0   40-45   24   20   4   0   0   40-45   21   6   4   0   0
   >45   98   22   7   0   0   >45   106   25   8   0   0   >45   103   20   5   0   0
   Total   2,919 2,416 1,997 1,103   100   Total   2,956 2,438 1,959 1,068   106   Total   3,038 2,528 2,110 1,251   142
 >$13,000 Mn   Observations   >$50,000 Mn   Observations   Full Universe   Observations
Sales CAGR (%)   1-Yr  3-Yr  5-Yr 10-Yr   20-Yr   Sales CAGR (%)   1-Yr   3-Yr  5-Yr 10-Yr   20-Yr   CAGR (%)   1-Yr   3-Yr   5-Yr 10-Yr 20-Yr
   <(25)   125   61   33   3   0   <(25)   29   17   16   1   0   <(25)   1,153 406   205   56   1
   (25)-(20)   42   25   27   2   0   (25)-(20)   7   5   4   1   0   (25)-(20)   471   246   126   14   1
   (20)-(15)   72   48   35   13   0   (20)-(15)   13   9   5   2   0   (20)-(15)   748   425   261   75   1
   (15)-(10)   120   92   66   34   0   (15)-(10)   27   20   10   12   0   (15)-(10)   1,147 875   564   149   4
   (10)-(5)   285   226   174   86   6   (10)-(5)   66   52   34   10   2   (10)-(5)   2,050 1,842 1,355 574   21
   (5)-0   568   573   482   279   35   (5)-0   110   115   97   49   4   (5)-0   3,695 3,508 3,184 1,796 131
   0-5   739   744   733   443   48   0-5   155   155   148   74   7   0-5   5,138 5,157 4,748 3,285 488
   5-10   571   526   423   291   35   5-10   120   107   79   55   3   5-10   4,489 4,104 3,606 2,485 294
   10-15   287   208   183   110   6   10-15   51   36   34   7   0   10-15   3,094 2,689 2,260 1,251 134
   15-20   168   109   81   34   0   15-20   30   16   8   1   0   15-20   2,004 1,672 1,332 589   44
   20-25   109   71   48   8   0   20-25   23   9   4   0   0   20-25   1,358 1,060 677   211   7
   25-30   65   40   13   3   0   25-30   11   3   2   0   0   25-30   929   625   397   80   7
   30-35   37   26   17   1   0   30-35   5   1   0   0   0   30-35   610   380   192   45   1
   35-40   27   16   5   0   0   35-40   4   2   0   0   0   35-40   469   282   116   26   2
   40-45   20   11   2   0   0   40-45   1   1   0   0   0   40-45   349   180   84   18   0
   >45   78   19   5   0   0   >45   13   1   0   0   0   >45   1,416 463   181   27   0
   Total   3,313 2,795 2,327 1,307   130   Total   665   549   441   212   16   Total   29,120 23,914 19,288 10,681 1,136
$2,250-3,500 Mn   Observations   $3,500-6,000 Mn   Observations   $6,000-13,000 Mn   Observations
Sales CAGR (%)   1-Yr  3-Yr  5-Yr 10-Yr   20-Yr   Sales CAGR (%)   1-Yr  3-Yr  5-Yr 10-Yr   20-Yr   Sales CAGR (%)   1-Yr  3-Yr  5-Yr 10-Yr   20-Yr
   <(25)   112   38   12   8   0   <(25)   110   33   17   3   0   <(25)   124   40   27   3   0
   (25)-(20)   45   23   8   3   1   (25)-(20)   37   24   15   1   0   (25)-(20)   51   30   14   0   0
   (20)-(15)   83   49   39   4   0   (20)-(15)   64   36   27   7   0   (20)-(15)   78   44   23   12   0
   (15)-(10)   112   97   68   21   1   (15)-(10)   128   95   61   11   0   (15)-(10)   111   103   68   18   0
   (10)-(5)   190   183   168   73   3   (10)-(5)   216   186   135   68   2   (10)-(5)   228   230   173   75   3
   (5)-0   373   367   333   216   14   (5)-0   405   403   351   204   18   (5)-0   425   458   455   271   19
   0-5   597   600   532   349   55   0-5   602   596   565   387   47   0-5   618   615   582   460   84
   5-10   473   408   358   246   17   5-10   512   460   367   217   35   5-10   522   443   393   279   28
   10-15   317   267   235   98   5   10-15   307   238   162   126   2   10-15   327   231   185   82   8
   15-20   203   158   117   59   3   15-20   185   138   120   35   2   15-20   168   137   95   33   0
   20-25   123   83   58   18   1   20-25   119   78   73   4   0   20-25   117   83   35   11   0
   25-30   83   59   29   4   0   25-30   66   39   34   4   0   25-30   69   48   36   1   0
   30-35   45   31   17   1   0   30-35   42   41   14   0   0   30-35   47   20   9   4   0
   35-40   40   21   7   3   0   35-40   33   26   6   1   0   35-40   29   20   6   2   0
   40-45   25   10   9   0   0   40-45   24   20   4   0   0   40-45   21   6   4   0   0
   >45   98   22   7   0   0   >45   106   25   8   0   0   >45   103   20   5   0   0
   Total   2,919 2,416 1,997 1,103   100   Total   2,956 2,438 1,959 1,068   106   Total   3,038 2,528 2,110 1,251   142
 >$13,000 Mn   Observations   >$50,000 Mn   Observations   Full Universe   Observations
Sales CAGR (%)   1-Yr  3-Yr  5-Yr 10-Yr   20-Yr   Sales CAGR (%)   1-Yr   3-Yr  5-Yr 10-Yr   20-Yr   CAGR (%)   1-Yr   3-Yr   5-Yr 10-Yr 20-Yr
   <(25)   125   61   33   3   0   <(25)   29   17   16   1   0   <(25)   1,153 406   205   56   1
   (25)-(20)   42   25   27   2   0   (25)-(20)   7   5   4   1   0   (25)-(20)   471   246   126   14   1
   (20)-(15)   72   48   35   13   0   (20)-(15)   13   9   5   2   0   (20)-(15)   748   425   261   75   1
   (15)-(10)   120   92   66   34   0   (15)-(10)   27   20   10   12   0   (15)-(10)   1,147 875   564   149   4
   (10)-(5)   285   226   174   86   6   (10)-(5)   66   52   34   10   2   (10)-(5)   2,050 1,842 1,355 574   21
   (5)-0   568   573   482   279   35   (5)-0   110   115   97   49   4   (5)-0   3,695 3,508 3,184 1,796 131
   0-5   739   744   733   443   48   0-5   155   155   148   74   7   0-5   5,138 5,157 4,748 3,285 488
   5-10   571   526   423   291   35   5-10   120   107   79   55   3   5-10   4,489 4,104 3,606 2,485 294
   10-15   287   208   183   110   6   10-15   51   36   34   7   0   10-15   3,094 2,689 2,260 1,251 134
   15-20   168   109   81   34   0   15-20   30   16   8   1   0   15-20   2,004 1,672 1,332 589   44
   20-25   109   71   48   8   0   20-25   23   9   4   0   0   20-25   1,358 1,060 677   211   7
   25-30   65   40   13   3   0   25-30   11   3   2   0   0   25-30   929   625   397   80   7
   30-35   37   26   17   1   0   30-35   5   1   0   0   0   30-35   610   380   192   45   1
   35-40   27   16   5   0   0   35-40   4   2   0   0   0   35-40   469   282   116   26   2
   40-45   20   11   2   0   0   40-45   1   1   0   0   0   40-45   349   180   84   18   0
   >45   78   19   5   0   0   >45   13   1   0   0   0   >45   1,416 463   181   27   0
   Total   3,313 2,795 2,327 1,307   130   Total   665   549   441   212   16   Total   29,120 23,914 19,288 10,681 1,136

资料来源:FactSet。

Source: FactSet.

尾注 1 Daniel Kahneman, Thinking, Fast and Slow (New York: Farrar, Straus and Giroux, 2011), 249. 2 Tesla Motors, Inc. Q4 2014 Earnings Call, February 11, 2015. See FactSet: callstreet Transcript, page 7. 3 Kahneman, 257.

Endnotes 1 Daniel Kahneman, Thinking, Fast and Slow (New York: Farrar, Straus and Giroux, 2011), 249. 2 Tesla Motors, Inc. Q4 2014 Earnings Call, February 11, 2015. See FactSet: callstreet Transcript, page 7. 3 Kahneman, 257.

4 See Small Business Association, Office of Advocacy, “Frequently Asked Questions,” January 2011 (https://www.sba.gov/sites/default/files/sbfaq.pdf) and Arnold C. Cooper, Carolyn Y. Woo, and William C. Dunkelberg, “Entrepreneurs’ Perceived Chances for Success,” Journal of Business Venturing, Vol. 3, No. 2, Spring 1988, 97-108.

4 See Small Business Association, Office of Advocacy, “Frequently Asked Questions,” January 2011 (https://www.sba.gov/sites/default/files/sbfaq.pdf) and Arnold C. Cooper, Carolyn Y. Woo, and William C. Dunkelberg, “Entrepreneurs’ Perceived Chances for Success,” Journal of Business Venturing, Vol. 3, No. 2, Spring 1988, 97-108.

5 Cade Massey, Joseph P. Simmons, and David A. Armor, “Hope Over Experience: Desirability and the Persistence of Optimism,” Psychological Science, Vol. 22, No. 2, February 2011, 274-281. Also, David A.

5 Cade Massey, Joseph P. Simmons, and David A. Armor, “Hope Over Experience: Desirability and the Persistence of Optimism,” Psychological Science, Vol. 22, No. 2, February 2011, 274-281. Also, David A.

Armor, Cade Massey, and Aaron M. Sackett, “Prescribed Optimism: Is It Right to Be Wrong About the Future?” Psychological Science, Vol. 19, No. 4, April 2008, 329-331. 关于乐观主义更详细的讨论,参见 Tali Sharot, The Optimism Bias: A Tour of the Irrationally Positive Brain (New York: Pantheon Books, 2011).

Armor, Cade Massey, and Aaron M. Sackett, “Prescribed Optimism: Is It Right to Be Wrong About the Future?” Psychological Science, Vol. 19, No. 4, April 2008, 329-331. For a more detailed discussion of optimism, see Tali Sharot, The Optimism Bias: A Tour of the Irrationally Positive Brain (New York: Pantheon Books, 2011).

6 若要试做这一测试,参见 http://confidence.success-equation.com/

6 To try the test, see http://confidence.success-equation.com/.

7 Geoffrey Friesen and Paul A. Weller, “Quantifying Cognitive Biases in Analyst Earnings Forecasts,” Journal of Financial Markets, Vol. 9, No. 4, November 2006, 333-365.

7 Geoffrey Friesen and Paul A. Weller, “Quantifying Cognitive Biases in Analyst Earnings Forecasts,” Journal of Financial Markets, Vol. 9, No. 4, November 2006, 333-365.

8 Itzhak Ben-David, John R. Graham, and Campbell R. Harvey, “Managerial Miscalibration,” Quarterly Journal of Economics, Vol. 128, No. 4, August 2013, 1547-1584.

8 Itzhak Ben-David, John R. Graham, and Campbell R. Harvey, “Managerial Miscalibration,” Quarterly Journal of Economics, Vol. 128, No. 4, August 2013, 1547-1584.

9 这些估计只涵盖约 1,200 家公司,但我们相信它对标普 1500 仍具代表性。

9 The estimates only include about 1,200 companies, but we believe it remains representative of the S&P 1500.

10 Bent Flyvbjerg, Massimo Garbuio, Dan Lovallo, “Better Forecasting for Large Capital Projects,” McKinsey on Finance, Autumn 2014, 7-13. Also, Bent Flyvbjerg, “Truth and Lies about Megaprojects,” Speech at Delft University of Technology, September 26, 2007.

10 Bent Flyvbjerg, Massimo Garbuio, Dan Lovallo, “Better Forecasting for Large Capital Projects,” McKinsey on Finance, Autumn 2014, 7-13. Also, Bent Flyvbjerg, “Truth and Lies about Megaprojects,” Speech at Delft University of Technology, September 26, 2007.

11 Kahneman, 249.

11 Kahneman, 249.

12 Berkeley J. Dietvorst, Joseph P. Simmons, and Cade Massey, “Algorithm Aversion: People Erroneously Avoid Algorithms After Seeing Them Err,” Journal of Experimental Psychology: General, Vol. 144, No. 1, February 2015, 114-126.

12 Berkeley J. Dietvorst, Joseph P. Simmons, and Cade Massey, “Algorithm Aversion: People Erroneously Avoid Algorithms After Seeing Them Err,” Journal of Experimental Psychology: General, Vol. 144, No. 1, February 2015, 114-126.

13 Alfred Rappaport and Michael J. Mauboussin, Expectations Investing: Reading Stock Prices for Better Returns (Boston, MA: Harvard Business School Press, 2001).

13 Alfred Rappaport and Michael J. Mauboussin, Expectations Investing: Reading Stock Prices for Better Returns (Boston, MA: Harvard Business School Press, 2001).

14 Rappaport and Mauboussin, 46. 只有当公司赚取的回报超过资本成本时,增长才创造价值。在负利差下的增长会毁灭价值。

14 Rappaport and Mauboussin, 46. Growth only creates value when a company earns in excess of the cost of capital. Growth at a negative spread destroys value.

15 多数上市公司的“死亡”是并购的结果。参见 Michael J. Mauboussin and Dan Callahan, “Why Corporate Longevity Matters: What Index Turnover Tells Us about Corporate Results,” Credit Suisse Global Financial Strategies, April 16, 2014. 另见 Madeleine I. G. Daepp, Marcus J. Hamilton, Geoffrey B. West, and Luís M. A. Bettencourt, “The mortality of companies,” The Royal Society Publishing, Vol. 12, No. 106, April 1, 2015.

15 Most public companies “die” as the result of mergers and acquisitions. See Michael J. Mauboussin and Dan Callahan, “Why Corporate Longevity Matters: What Index Turnover Tells Us about Corporate Results,” Credit Suisse Global Financial Strategies, April 16, 2014. Also, Madeleine I. G. Daepp, Marcus J. Hamilton, Geoffrey B. West, and Luís M. A. Bettencourt, “The mortality of companies,” The Royal Society Publishing, Vol. 12, No. 106, April 1, 2015.

16 Michael H. R. Stanley, Luís A. N. Amaral, Sergey V. Buldyrev, Shlomo Havlin, Heiko Leschhorn, Philipp Maass, Michael A. Salinger, and H. Eugene Stanley, “Scaling Behaviour in the Growth of Companies,” Nature, Vol. 379, February 29, 1996, 804-806. Also, Rich Perline, Robert Axtell, and Daniel Teitelbaum, “Volatility and Asymmetry of Small Firm Growth Rates Over Increasing Time Frames,” Small Business Research Summary, No. 285, December 2006.

16 Michael H. R. Stanley, Luís A. N. Amaral, Sergey V. Buldyrev, Shlomo Havlin, Heiko Leschhorn, Philipp Maass, Michael A. Salinger, and H. Eugene Stanley, “Scaling Behaviour in the Growth of Companies,” Nature, Vol. 379, February 29, 1996, 804-806. Also, Rich Perline, Robert Axtell, and Daniel Teitelbaum, “Volatility and Asymmetry of Small Firm Growth Rates Over Increasing Time Frames,” Small Business Research Summary, No. 285, December 2006.

17 Tim Koller, Marc Goedhart, and David Wessels, Valuation: Measuring and Managing the Value of Companies, 5th Edition (Hoboken, NJ: John Wiley & Sons, 2010). Also, Patrick Viguerie, Sven Smit, and Mehrdad Baghai, The Granularity of Growth: How to Identify the Sources of Growth and Drive Enduring Company Performance (Hoboken, NJ: John Wiley & Sons, 2008).

17 Tim Koller, Marc Goedhart, and David Wessels, Valuation: Measuring and Managing the Value of Companies, 5th Edition (Hoboken, NJ: John Wiley & Sons, 2010). Also, Patrick Viguerie, Sven Smit, and Mehrdad Baghai, The Granularity of Growth: How to Identify the Sources of Growth and Drive Enduring Company Performance (Hoboken, NJ: John Wiley & Sons, 2008).

18 Sheridan Titman, K. C. John Wei, and Feixue Xie, “Capital Investments and Stock Returns,” The Journal of Financial and Quantitative Analysis, Vol. 39, No. 4, December 2004, 677-700.

18 Sheridan Titman, K. C. John Wei, and Feixue Xie, “Capital Investments and Stock Returns,” The Journal of Financial and Quantitative Analysis, Vol. 39, No. 4, December 2004, 677-700.

19 William M. K. Trochim and James P. Donnelly, The Research Methods Knowledge Base, Third Edition (Mason, OH: Atomic Dog, 2008), 166. See http://www.socialresearchmethods.net/kb/regrmean.php.

19 William M. K. Trochim and James P. Donnelly, The Research Methods Knowledge Base, Third Edition (Mason, OH: Atomic Dog, 2008), 166. See http://www.socialresearchmethods.net/kb/regrmean.php.

20 Michael J. Mauboussin, Dan Callahan, Bryant Matthews, and David A. Holland, “How to Model Reversion to the Mean: Determining How Fast, and to What Mean, Results Revert,” Credit Suisse Global Financial Strategies, September 17, 2013.

20 Michael J. Mauboussin, Dan Callahan, Bryant Matthews, and David A. Holland, “How to Model Reversion to the Mean: Determining How Fast, and to What Mean, Results Revert,” Credit Suisse Global Financial Strategies, September 17, 2013.

21 “Credit Suisse Global Investment Returns Yearbook 2014,” Credit Suisse Research Institute, February 2014, 31-35. 22 Louis K.C. Chan, Jason Karceski, and Josef Lakonishok, “The Level and Persistence of Growth Rates,”

21 “Credit Suisse Global Investment Returns Yearbook 2014,” Credit Suisse Research Institute, February 2014, 31-35. 22 Louis K.C. Chan, Jason Karceski, and Josef Lakonishok, “The Level and Persistence of Growth Rates,”

Journal of Finance, Vol. 58, No. 2, April 2003, 643-684. Also, Michael J. Mauboussin, “The True Measures of Success,” Harvard Business Review, October 2012, 46-56.

Journal of Finance, Vol. 58, No. 2, April 2003, 643-684. Also, Michael J. Mauboussin, “The True Measures of Success,” Harvard Business Review, October 2012, 46-56.

23 只要公司仍然存续,这些计算实际上就一直把它纳入在内,即使它已退出标普 1500 指数。我们还剔除了增长率最高和最低的各 5%。增长率位居最高 5% 的公司,通常是规模极小的企业,或是进行过重大并购活动的企业。24 参见 http://www.imore.com/tim-cook-goldman-sachs-conference

23 The calculations actually capture each company as long as it remains in existence, even if it leaves the S&P 1500 Index. We also trim the top and bottom five percent of the growth rates. Companies with growth rates in the top five percent are generally extremely small firms or firms that engaged in a significant merger and acquisition activity. 24 See http://www.imore.com/tim-cook-goldman-sachs-conference.

25 Dan Lovallo and Daniel Kahneman, “Delusions of Success: How Optimism Undermines Executives’

25 Dan Lovallo and Daniel Kahneman, “Delusions of Success: How Optimism Undermines Executives’

Decisions,” Harvard Business Review, July 2003, 56-63.

Decisions,” Harvard Business Review, July 2003, 56-63.

26 Warren E. Buffett, “Letter to Shareholders,” Berkshire Hathaway Annual Report, 2000. See http://www.berkshirehathaway.com/2000ar/2000letter.html.

26 Warren E. Buffett, “Letter to Shareholders,” Berkshire Hathaway Annual Report, 2000. See http://www.berkshirehathaway.com/2000ar/2000letter.html.